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Abstract 
The primary purpose of this study was to test the hypotheses that in young, 
normotensive men and women, 10 weeks of isometric handgrip (IHG) training (3X/ 
week) would 1) elicit reductions in ambulatory blood pressure (BP), concomitant to 
reductions in resting BP, and 2) these reductions would be predicted by cardiovascular 
reactivity to standard laboratory stress tasks (e.g. IHG task, IHGT; a 2 minute sustained 
isometric contraction). Reductions in 24-hour, daytime, and nighttime systolic 
ambulatory BP were observed following IHG training in both men (n=13) and women 
(n=11, P<0.05). These reductions were concomitant to reductions in resting systolic BP 
in both men (n=13) and women (n=13, P<0.05). Reductions in resting systolic BP, but 
not ambulatory BP (P>0.05), were associated with pre-training systolic BP reactivity to 
the IHGT (P<0.05). These findings are important for primary prevention of HT in young, 
normotensives and indicate that the IHGT can be a useful tool for predicting responders 
to IHG training. 
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1.1 Cardiovascular Disease and Hypertension 
 
1.1.1 Introduction 
 
With the rising tide of an aging population, population growth, rapid urbanization, 
and the globalization of unhealthy lifestyles, disease patterns have fundamentally 
changed (Smith et al., 2012). Non-communicable diseases, in particular cardiovascular 
disease (CVD), have surpassed the global health’s burden of infectious diseases (Smith et 
al., 2012). Recently, the World Health Organization (WHO) identified CVD as the 
leading cause of death globally (WHO, 2013). CVD is an umbrella term which describes 
a plethora of disorders influencing the heart and blood vessels. These include coronary 
heart disease, cerebrovascular disease, elevated blood pressure (hypertension; HT), 
peripheral arterial disease, rheumatic heart disease, congenital heart disease, and heart 
failure (WHO, 2013).  Accounting for approximately 17 million deaths per annum 
worldwide (WHO, 2013), CVD incidence is projected to increase to more than 23.6 
million by the year 2030 (Smith et al., 2012). Approximately one third of deaths in 
Canada can be attributed to CVD, posing a considerable expense to the Canadian 
healthcare system (Oliveira et al., 2012).  In 2005, expenditures in Canada relating to 
CVD were approximately $20.9 billion and are projected to rise to $28.3 billion by the 
year 2020 (Theriault et al., 2010). With the current prevalence and economic burden on 
global healthcare, and the expected increases in both, prevention and control of CVD is 
of utmost importance.  
1.1.2 Classification/Definition of HT 
 
HT, a chronically sustained elevation in arterial blood pressure (BP), is a major 
cause of morbidity and mortality due to its association with CVD related events such as 
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coronary heart disease and stroke. In 2013, the WHO deemed HT a global health crisis 
and predicts an epidemic of HT in the near future (WHO, 2013). Arterial BP is a 
dichotomous measure comprising systolic and diastolic BP, which represent different 
phases of the cardiac cycle (Herd, 1970). Systolic BP represents the maximum pressure 
exerted on the arteries and occurs during ventricular contraction (Herd, 1970). 
Conversely, diastolic BP is the pressure that is exerted on the walls of arteries when the 
heart is relaxed and the ventricles are filling with blood (Herd, 1970). Normal values of 
resting systolic BP and diastolic BP for adults are <120 mmHg and <80mmHg, 
respectively (WHO, 2013). Individuals with pre-hypertension have a resting systolic BP 
between 120-139 mmHg and/or a diastolic BP between 80-89 mmHg. Pre-hypertension 
can lead to HT development and, thus, represents a significant risk for CVD (WHO, 
2013). Conversely, HT is defined as a resting systolic BP ≥ 140 mmHg and/or a diastolic 
BP ≥ 90 mmHg. HT can be further classified into Stage 1 and Stage 2 (WHO, 2013). 
Resting  BP (systolic BP/diastolic BP) within the range of 140-150/90-99 mmHg is 
classified as Stage 1 HT, whereas resting BP > 160/100 mmHg is defined as Stage 2 HT 
(WHO, 2013). Recently, ambulatory BP, a measure that provides insight into the 24-hour 
fluctuations in BP, has been found to be a more efficacious predictor of CVD morbidity 
and mortality than conventional resting BP measurements (O’Brien et al., 2003; 
Pickering et al., 2006; O’Brien et al., 2007). Typically, ambulatory BP monitors are 
programmed to measure BP every 15-30 minutes throughout the daytime (6 a.m. – 10 
p.m.) and every hour throughout the nighttime (10 p.m. – 6 a.m.) during a 24-hour time 
period (Stiller-Moldovan et al., 2012; Pickering et al., 2006). These recordings are 
subsequently averaged to generate a mean 24-hour, daytime, and nighttime ambulatory 
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systolic and diastolic BP reading (Pickering et al., 2006). Individuals who have a mean 
24-hour ambulatory BP > 130/80 mmHg and/or a daytime ambulatory BP > 135/85 
mmHg for systolic BP and diastolic BP, respectively, are considered for a diagnosis of 
HT (Pickering et al., 2006). Normotensive counterparts have a diurnal rhythm of BP 
where BP falls 10 – 20% during the nighttime period (Pickering et al., 2006). In patients 
with HT, this nocturnal fall in BP is often diminished (<10%), and has been speculated to 
cause an increased risk for CVD development (Pickering et al., 2006). Thus, nighttime 
ambulatory BP has been identified as a more accurate predictor of CVD risk (O’Brien et 
al., 2003; O’Brien et al., 2007; Cohen & Townsend, 2010; Hansen et al., 2010) 
The pathophysiology of HT is painted with some uncertainty. Between 2-5% of 
patients have underlying renal or adrenal diseases that are direct causes of sustained 
elevations in BP (Beevers et al., 2001). This form of HT, known as secondary HT, is 
considered reversible as the underlying pathophysiology of disease development is 
largely identifiable (Chobanian et al., 2003).  However, in the remainder of patients no 
single identifiable cause can be established and the condition is labelled essential or 
primary HT (Beevers et al., 2001). 
1.1.3 Measuring Arterial BP 
 
Measurement of arterial BP can be divided into invasive and non-invasive 
methods. The method of obtaining the most accurate reading of resting BP is invasively 
through an arterial line (Perloff et al., 1993).  This is a direct measure of arterial BP as it 
involves placing a catheter directly into the artery (Kim et al., 2011; Perloff et al, 1993). 
Although an accurate measure, arterial lines are infrequently used in clinical settings due 
to the invasive nature of the technique (Kim et al., 2011). With this being the case, a 
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number of reliable non-invasive procedures have been developed. Among them include 
auscultatory sphygmomanometry and oscillometry, which are the most widely used 
methods of measuring BP. Ambulatory BP monitoring can be classified under 
oscillometry and as mentioned in Section 1.1.2 , has recently gained interest in the 
clinical community as a better predictor of CVD risk (O’Brien et al., 2003; Pickering et 
al., 2006; O’Brien et al., 2007).  
Auscultatory Sphygmomanometry 
The auscultatory sphygmomanomety device is employed to determine resting BP 
by means of monitoring Kortokoff sounds. In this method, an inflatable cuff is placed 
around the upper arm in order to occlude the brachial artery. The cuff is inflated manually 
to approximately 200 mmHg or until the artery is completely occluded. As the pressure in 
the cuff is slowly released, a stethoscope is placed over the brachial artery to detect 
auditory changes (Pickering et al., 2005). The blood that begins to flow into the artery is 
turbulent and causes oscillations in the arterial wall (Korotokoff, 1905). The initiation of 
blood flow elicits a pulse synchronic pounding which is termed the first Korotkoff sounds 
and represent systolic BP. The pressure in the cuff is further released until no audible 
sound can be detected at diastolic BP (Korotkoff, 1905).   
Although this non-invasive method is considered the gold standard of arterial BP 
measurement in clinical practise, there exist several limitations inherent to the protocol. 
The most notable disadvantages of employing this method include observer error, 
observer measurement bias, influence of cuff size and placement of cuff, and external 
noise disturbances (Beevers et al., 2001).   
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Oscillometric Method 
The osciollometric technique is another form of non-invasive BP measurement 
and, like auscultatory sphygmomanometry, requires the placement of an inflatable cuff 
around the upper arm (Langewouters et al., 1998).  The mechanism of detecting BP from 
the brachial artery  using this method relies on oscillations within the cuff during gradual 
deflation. Oscillations are detected at systolic BP and cease below diastolic BP. 
Subsequently, values of systolic BP and diastolic BP are computed using an empirically 
derived algorithm (Langewaouters et al., 1998; Pickering et al., 2005). The described 
technique has a number of advantages over the auscultatoric method as it is less 
susceptible to external noise disturbance, does not rely on human auditory acuity, and 
does not require a transducer rendering accuracy of cuff placement less critical (Pickering 
et al., 2005).  Despite these significant advantages, oscillometry comes with one notable 
disadvantage. That is, detection of oscillations within the cuff can be influenced by other 
factors, such as arterial stiffness. If this is the case, mean arterial BP may be 
underestimated (Pickering et al., 2005). 
Ambulatory BP monitoring  
The currently available ambulatory monitors employ the oscillometric technique, 
as described above, and can record BP measured at the brachial artery for 24 hours or 
longer (O’Brien et al., 2003). The monitor can be worn on a belt or in a pouch and is 
attached to a sphygmomanometer cuff placed around the upper arm by a plastic tube 
(O’Brien et al., 2003; O’Brien et al., 2007). The monitors are typically programmed to 
inflate and take readings every 15 to 30 minutes (Pickering et al., 2006) during the day (6 
a.m. – 10 p.m.) and every hour during nighttime (10 p.m. – 6 a.m.) and subsequently 
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generates a mean 24-hour, daytime, and nighttime ambulatory BP reading (Pickering et 
al., 2006).  
Ambulatory BP monitoring is regarded by many as the gold standard for the 
prediction of CVD risk related to elevated arterial BP, since prognostic studies have 
shown that it predicts clinical outcome better than conventional resting BP measurements 
(O’Brien et al., 2007). Ambulatory BP monitoring provides a profile of BP away from 
the medical environment, thereby allowing identification of individuals with a white-coat 
response where BP elevations can be attributed to anxiety from being in a clinical setting. 
Ambulatory BP monitoring can also provide a better profile of the efficacy of anti-
hypertensive medication (O’Brien et al., 2007). Moreover, growing evidence suggests 
that nocturnal BP measured by ambulatory BP monitoring may be the most sensitive 
predictor of CVD outcome (O’Brien et al., 2003; O’Brien et al., 2007; Cohen & 
Townsend, 2010). 
1.1.4 Regulation of BP 
 
Before discussing the pathophysiology of HT, understanding the mechanisms 
behind BP regulation in a healthy state is of importance. The necessity in having well 
developed mechanisms to tightly control BP is due to the continuous blood flow 
requirements of each tissue to meet the given metabolic demand (Ackerman, 2004).   
Regulation of BP is associated with the manipulation of three cardiovascular 
parameters. The three control points include the rate of contraction of the heart (heart 
rate, HR), the volume of blood pumped per heart beat stroke volume, SV), and the sum of 
the resistance of all peripheral vasculature in the systemic circulation (total peripheral 
resistance, TPR) (Ackerman, 2004). Arterial BP is a result of the product of cardiac 
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output (Q) and TPR, where Q is the product of HR and SV. Modulation of BP can occur 
by manipulation of Q, via HR and/or SV, and/or TPR via changes in arterial diameter 
through vasodilation or vasoconstriction of vascular smooth muscle (Ackerman, 2004). 
Stringent control of BP is accomplished by the coordinated action of several innate 
pathways including neural, local, and hormonal control mechanisms.  
Neural Regulation 
The constituents of the autonomic nervous system (ANS), the sympathetic 
nervous system (SNS) and the parasympathetic nervous system (PNS) play an integral 
role in arterial BP regulation. SNS activation causes increases in TPR and HR, leading to 
increases in Q, thereby increasing BP (Dampney et al., 2012). Conversely, PNS 
activation results in decreases in HR and slight reductions in force of myocardial 
contraction, resulting in reductions in Q and BP (Dampney et al., 2012).  
Neural control of BP relies primarily on ANS inputs received by the 
cardiovascular control center (CCC) from the central command (CC), which are both 
higher brain regions (Victor et al., 1995). The CCC serves as the hub for integration of 
SNS and PNS activity (Dampney et al., 2012; Victor et al., 1995). In addition to receiving 
efferent signals from the CC, the CCC also integrates signals from peripheral receptors. 
Among these, the most influential include arterial baroreceptors, chemoreceptors, and 
muscle afferent receptors.  
Arterial baroreceptors, located in the heart, pulmonary vessels, and carotid artery, 
can detect conformational changes to the vessel wall and are thus classified as stretch 
receptors (Lafranchi & Somers, 2002).  The contribution to BP regulation by arterial 
baroreceptors is accomplished via afferent feedback to the CCC (Lafranchi & Somers, 
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2002). If BP increases to a non-homeostatic range, the stretch receptors will respond to 
this change in pressure and transmit impulses to the CCC. This in turns allows the CCC 
to augment SNS and PNS activity to maintain homeostasis of BP (Lafranchi & Somers, 
2002).   
 The chemoreceptor reflex response is another example of feedback regulation of 
BP. Chemoreceptors, located in the carotid and aortic bodies, detect reductions in partial 
pressure of oxygen (PaO2), increases in partial pressure of carbon dioxide (PaCO2), as 
well as increases in hydrogen ion concentration ([H
+
]) (Prabhakar, 2000). An example of 
a scenario where these changes become significant is during moderate to rigorous 
exercise. The response to these changes involves the transmission of impulses to the 
CCC, subsequently inducing vasoconstriction of vascular beds to increase TPR as well as 
stimulating ventilation to increase oxygen uptake in the blood leading to an increase in 
BP (Prabhakar, 2000). 
There are two primary muscle afferent receptors involved in BP regulation. 
Mechanoreceptors (Type III afferents), like arterial baroreceptors, detect stretch and 
mechanical deformation due to pressure changes within the arterial walls. Whereas 
metaboreceptors (Type IV afferents), respond to chemical stimuli and metabolic by-
products such as lactic acid, deprotonated phosphate, potassium, bradykinin, serotonin, 
and adenosine (Leshnower et al., 2001). Impulses from both these receptors are sent to 
and integrated in the CCC,  resulting in augmentation of ANS activity leading to an 
increase or decrease in BP and HR (Leshnower et al., 2001). 
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Hormonal Regulation  
Arterial BP can be regulated by various hormones of the neuroendocrine system. 
The most influential being the catecholamines (secreted by the adrenal medulla), 
antidiuretic hormone (secreted by the pituitary gland), atrial natriuretic peptide (released 
by the heart), renin (secreted by the kidneys), and aldosterone (secreted by the adrenal 
cortex). 
The catecholamines, norepinephrine (NE) and epinephrine (E) are secreted in 
response to SNS activation (Manneli et al., 1990). NE and E induce different 
cardiovascular responses, involving modulation to Q and TPR, based on the receptor it is 
bound to and its location in the body. The two receptors which interact with NE and E 
include -adrenergic receptors (1 and 2-receptors) and -adrenergic receptors (1 and 
2-receptors). The subdivision of receptors is based on location and mechanism of action 
(Ruffolo et al., 1991). NE and E elicit increases in TPR via vasoconstriction of the 
vascular walls when bound to 1 and 2-receptors, respectively (Manneli et al., 1990). E 
induces vasodilation of blood vessels when bound to 2 receptors, resulting in decreases 
of arterial BP via decreases in TPR (Manneli et al., 1990). In terms of modulation of Q, E 
can evoke stimulatory effects to HR via a second messenger cellular cascade. The 
terminating signal modulates SA nodal activity and diastolic filling time, resulting in 
increases to HR, thereby increasing BP (Opie, 2004; Larsson, 2010).   
Stimulation of the PNS neurons regulates BP in an opposing fashion via the 
release of the neurotransmitter acetylcholine (ACh). ACh binds to muscarinic receptors 
on the cardiac cell membrane, leading to inhibition of adenylyl cyclase, resulting in an 
inhibition to increases in intracellular cAMP (Brodde & Michel, 1999). The net effect of 
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this cascade is a reduction in calcium influx, which reduces the force of myocardial 
contraction, thereby reducing Q and BP. In addition to myocardial contractility, the 
release of ACh also affects HR by causing a hyperpolarization of the SA node. The result 
is a reduction in the rate of depolarization of the SA node causing HR to decrease and 
thus a reduction in BP (Brodde & Michel, 1999). 
Atrial natriuretic peptide (ANP), a cardiac hormone, is involved in the 
physiological maintenance of blood volume and BP (Potter et al., 2006). Its release is 
contingent on detection of arterial wall stretch within the heart due to increases in BP. 
Thus, the role of ANP is to lower BP by reducing:1) TPR by preventing vasoconstriction 
of the vascular walls (achieved by inhibiting actin-myosin binding, which dilates smooth 
muscle), and 2)  total blood volume by promoting diuresis and modulating sodium and 
water retention (Chen et al., 2008).  
Vasopressin (AVP), or antidiuretic hormone, is a potent vasoconstrictor which 
modulates water retention. It is stored in the posterior pituitary gland and is released into 
the blood in response to a decrease in BP (Holmes et al., 2004).  AVP relies on two 
mechanisms to increase BP: 1) increases TPR via direct vasoconstriction of smooth 
muscles (Holmes et al., 2004; Henderson & Bryon, 2007), and 2) increases water 
retention by promoting water resorption from the kidney. The latter, in turn, increases 
blood volume, thereby increasing BP (Nielson et al., 1995).  
The renin-angiotensin-aldosterone system (RAAS), a hormone system that 
regulates blood volume and vascular tone, is considered the most important long-term 
regulator of arterial BP (Carey & Siragy, 2003). Instigation of the RAAS is by renin; a 
protein enzyme released by the kidneys. Renin cleaves angiotensinogen, a pro-hormone 
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released by the liver, to form angiotensin I (Nguyen et al., 2002). Angiotensin I is then 
converted to angiotensin II, the more active form, facilitated by angiotensin converting 
enzyme (ACE). Angiotensin II, a potent vasoconstrictor, increases BP via increases in 
TPR (Nguyen et al., 2002; Donoghue et al., 2000). Moreover, angiotensin II initiates the 
release of the hormone aldosterone from the adrenal cortex. By conserving sodium, 
aldosterone promotes water resorption, leading to an increase in blood volume and BP 
(Hall et al., 1989).  
Local Regulation 
Lastly, arterial BP can be regulated locally by the action of vasoactive chemicals 
that are triggered in response to the metabolic needs of the body’s organs and tissues. 
Vascular smooth muscle plays a crucial role in BP control by varying TPR via 
vasoconstriction and vasodilation of arterioles (Webb, 2003). Modulation of vascular 
tone is mediated primarily by potassium, adenine derivatives, and endothelium-derived 
substances such as nitric oxide (NO
-
) and endothelin-1 (ET-1) (Webb, 2003). 
Potassium accumulation in the interstitium is a result of increases in muscle 
activity, leading to stimulation of the sodium-potassium pump in vascular smooth muscle 
cells (Haddy et al., 2006). Due to unequal pumping of ions, the cell becomes 
hyperpolarized. This in turn causes relaxation of the smooth muscle, followed by 
vasodilation of the arteriole, thereby increasing blood flow (Haddy et al., 2006). 
Adenosine, adenosine monophosphate (AMP), adenosine diphosphate (ADP), and 
adenosine triphosphate (ATP) are derivatives of adenine and act as vasodilators. During 
muscular contraction, ATP is catabolized, and the accumulation of its by-products causes 
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vasodilation in the arterioles in order to meet the increased demand for blood perfusion to 
the exercising tissues (Haddy & Scott, 1968). 
NO
-
, also a potent vasodilator, is produced by the endothelium in response to 
mechanical (e.g., shear stress) or chemical (e.g., ACh) stimuli acting on endothelial cells 
(Umans and Levi, 1995; Brodde & Michel, 1999). Synthesis of NO
- 
from L-arginine is 
catalyzed by the enzyme NO synthase (eNOS).  The release of NO
-
 promotes relaxation 
of vascular smooth muscle, resulting in decreases in TPR, thereby increasing blood flow 
(Corson et al., 1996). 
To counterbalance the production of vasodilating substances, the endothelium 
also synthesizes a number of vasocontricting substances. In particular, ET-1 is the most 
potent of these, and its release, like NO
-
, is signalled by chemical (e.g. angiotensin II, 
catecholamine, cytokine, hypoxic, growth factor) or mechanical (i.e. sheer stress) 
stimulation (Touyz & Shiffrin, 2003). Bound to the ETA receptor, ET-1 induces 
vasoconstriction resulting in increases in TPR, thus increasing arterial BP. ET-1 plays a 
dual role and can also act to mediate vascular tone via a negative feedback loop. Binding 
to ETB receptors triggers the release of NO
- 
resulting in vasodilatory effects as previously 
mentioned (Pollock et al., 1995). 
1.1.5 Sex Differences in Arterial BP Regulation 
 
Sex has an important influence on the regulation of arterial BP. Pre-menopausal 
women have consistently been found to have lower BP values than age-matched men 
(Dubey et al., 2002). Conversely, evidence suggests that post-menopausal women have 
higher BP values than pre-menopausal women, suggesting ovarian hormones may play a 
role in modulation of BP (Dubey et al., 2002). 
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 It is postulated that sex and sex hormones can modulate the level of resting SNS 
activity with this effect contributing to the differences in regulation of BP in men and 
women. Muscle sympathetic nerve activity (MSNA), a common measurement of central 
SNS activity, is consistently found to be lower in young, normotensive women than in 
age-matched men (Hart et al., 2009). In young men, SNS activity is directly proportionate 
to the vasoconstrictor tone in the peripheral vasculature. This relationship does not exist 
in pre-menopausal women, suggesting that female sex hormones may offset the transfer 
of SNS activity into vasoconstrictor tone (Hart et al., 2009; Hart &Charkoudian, 2011). 
Hart and colleagues (2011) recently explored the sex differences in β‐adrenergic 
stimulation. Study investigators found that in pre-menopausal women, the β‐adrenergic 
receptors, involved in vasodilation, blunt the vasoconstrictor effect of SNS activity. This 
mechanism was not observed in age-matched men or  post-menopausal women (Hart et 
al., 2011). This study provides insight into the mechanisms behind sex differences in 
arterial BP and may explain why risk of HT development is higher in young men and 
post-menopausal women. 
1.1.6 Pathophysiology of Primary (Essential) HT 
  
There are a number of risk factors associated with the development of CVD. 
Family history, gender, ethnicity, medical history, and age are among the non-modifiable 
risk factors (Beevers et al., 2001). Although these variables cannot be altered, CVD is 
largely considered preventable due to the significant number of behavioural factors that 
account for disease development. These include tobacco exposure, physical activity, body 
composition, blood cholesterol levels, alcohol intake, diet, stress, and HT (Beevers et al., 
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2001). With respect to the latter, it is well accepted and recognized by the WHO that HT 
is one of the leading modifiable risk factors for CVD (WHO, 2013). 
Primary (essential) HT is the most common form of HT, as previously noted, and 
will thus be the focus of discussion below. The maintenance of BP is directed by a 
number of physiological mechanisms including neural, local, and hormonal factors, as 
discussed in Section 1.1.4. Derangement to one or more of these regulatory pathways is 
thought to play an important role in the development of primary HT, and is attributed to a 
number of interrelated variables with their relative role varying between individuals. 
Lifestyle, the RAAS, vascular factors, and the SNS have been elaborately studied as 
mediators of primary HT, as well as less modifiable genetic and environmental factors 
(Beevers et al., 2001).  
Lifestyle factors that contribute to HT development include obesity, insulin 
resistance, excessive sodium intake, excessive alcohol intake, leading a sedentary 
lifestyle, excessive stress, low potassium intake, and/or low calcium intake (Beevers et 
al., 2001; Coylewright, 2008).   
Numerous studies have reported a link between overactive SNS activity and HT 
development (Singh et al., 2010). Chronically increased SNS activity contributes to HT 
via its stimulatory effects on the heart, vasculature, and kidneys (Mark, 1996). The result 
is increases in Q, TPR, and water retention, thereby leading to an elevated resting BP 
(DiBona, 2004).  
Disturbances to the RAAS, the most potent of the endocrine systems in regulation 
of BP as elaborated in Section 1.1.4, have been implicated in HT. Particularly, high or 
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abnormal circulating levels of renin and the resultant increased production of angiotensin 
II and aldosterone can contribute to disease development (Singh et al., 2010). 
Disturbances to the balance of endothelial-derived vasoconstrictors and 
vasodilators play a role in  HT development. It has been well established in the literature 
that HT is associated with endothelial dysfunction. The dysfunction rests in endothelium-
dependent vasodilation due to a reduction in formation of and/or bioavailable NO (Panza 
et al., 1990). Additionally, increases in ET-1, a potent vasoconstrictor, can be observed in 
individuals with HT as it increases TPR (Schiffrin, 1999). 
The role that genetics plays in primary HT development is considerable. Genetic 
factors in combination with environment and lifestyle factors are postulated to have a 
significant impact in contributing to disease progression (Singh et al., 2010).The 
pathogenesis of HT is complex and yet to be fully elucidated. With a clearer 
understanding of disease development and progression, a greater reduction in HT-related 
morbidity can be accomplished via more targeted therapies.   
1.1.7 Prevention and Treatment of HT 
 
In Canada and worldwide, the prevention of HT currently present as major public 
health challenges and the WHO has recently declared primary prevention of HT a key 
priority (WHO, 2013; Chobanian et al., 2003). From a secondary prevention perspective, 
the primary goal of anti-hypertensive therapy is to lower resting systolic BP and diastolic 
BP to <140 mmHg and <90 mmHg, respectively (WHO, 2013). For individuals with 
prehypertension, the recommendation is to lower resting systolic BP and diastolic BP to 
<120 mmHg and <80 mmHg, respectively (WHO, 2013). Although less definitive, it is 
recommended to lower 24-hour ambulatory systolic BP and diastolic BP to <130 mmHg 
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and <80 mmHg, and daytime ambulatory systolic BP and diastolic BP to <135 mmHg 
and <85 mmHg, respectively (Pickering et al., 2006). Current recommendations include 
lifestyle modifications as the foremost prevention and treatment strategy (WHO, 2013).   
Engaging in healthy dietary habits and meeting the guidelines for physical activity 
are important components in the prevention of HT and are indispensable to the 
management of HT (Pescatello et al., 2004; Chobanian et al., 2003). Changes to dietary 
food composition involve restricting alcohol intake, limiting sodium consumption, and 
maintaining a healthy body weight (Chobanian et al., 2003). Adopting the Dietary 
Approaches to Stop Hypertension (DASH) is also recommended for HT management. 
The DASH diet is rich in fruits, vegetables, and low fat dairy products with a reduced 
content in saturated fat and cholesterol (Blumenthal et al., 2010; Chobanian et al., 2003). 
Employment of the DASH diet in numerous intervention studies have reported significant 
decreases in both systolic BP and diastolic BP, with an additive effect of reducing sodium 
intake, resulting in much greater decreases in resting BP (Vollmer et al., 2001; Sacks et 
al., 2001; Roberts et al., 2002). Regular physical activity is an integral element of 
maintaining a normal arterial BP and its effects will be elaborated below in Section 1.1.8. 
If such modifications fail to generate acceptable reductions in BP to within target 
ranges, pharmacological therapy is recommended in adjunct to lifestyle changes (Khan et 
al., 2007). The different classes of pharmaceuticals aim to target different pathological 
mechanisms of HT and include diuretics, ACE inhibitors, beta blockers, and angiotensin 
receptor blockers as the most widely used (Chobanian et al., 2003). The class of drug is 
denoted by site of action. The role these substances play in decreasing resting arterial BP 
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is through modulation of Q and/or TPR with aim to attenuate the complications 
associated with HT (Chobanian et al., 2003).  
 
1.2 Exercise and Hypertension 
   
Within the recommendations for lifestyle modifications, exercise, as mentioned in 
the previous section, is an integral component of HT prevention and management. A 
plethora of studies provide convincing evidence that engaging in physical activity can 
have a profound effect in keeping BP values within appropriate homeostatic ranges. The 
current report from the American College of Sports Medicine (ACSM) on physical 
activity guidelines for HT management recommends 30-to-60 minutes of moderate (40 to 
<60% of an individual’s HR reserve, calculated as: [(HRmax − HRrest) X desired intensity] 
+ HRrest) aerobic activity (i.e. walking, jogging, cycling) performed on most, preferably 
all days of the week (Thompson, 2014). It is recommended that in addition to aerobic 
exercise, dynamic resistance training (i.e. lifting weights) is performed 2 to 3 times per 
week, and should consist of at least one set of 8-12 repetitions for each of the major 
muscle groups (Thompson, 2014). Guidelines for isometric training, a subdivision of 
resistance training involving static movements, were until recently unavailable. On 
account of accumulating evidence, the AHA recommends for the first time in their 
recently published guidelines the use of isometric handgrip (IHG) exercise as a method of 
HT management. Specifically, 2 minute sustained contractions should be performed at 
30% of maximal voluntary strength (maximal voluntary contraction, MVC) to total 12-15 
minutes per session, at least 3 times a week over a period of 8-12 weeks (Brook et al., 
2015; Brook et al., 2013). 
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1.2.1 Acute Effects of Aerobic Exercise on BP 
 
Engaging in an acute bout of aerobic exercise elicits immediate increases in HR 
and Q, leading to an increase in systolic BP (MacDonald, 2002). These acute modulations 
occur to satisfy tissue perfusion. Following the immediate rise in systolic BP, there is a 
gradual reduction as the arterioles supplying the muscles vasodilate to meet the demand 
of the working muscles, thereby reducing TPR leading to a reduction in BP (MacDonald, 
2002).  
Acute aerobic exercise can promote lowering of resting BP during the post-
exercise period. This phenomenon is termed post-exercise hypotension (PEH) and has 
been observed up to 22 hours following the exercise bout (Rondon et al., 2002; Kenney 
& Seals., 1993). The mechanisms behind this remain unclear but it is speculated that the 
observed decrease in BP is either due to decreases in TPR via inhibited sympathetic 
outflow and/or release of local vasodilatory compounds (Floras et al., 1989; Pescatello et 
al., 2005). 
Specifications of the aerobic exercise itself are important in determining the 
degree of PEH, however the effect of exercise intensity remains a controversial topic. 
Pescatello and colleagues (1991) reported no differences in PEH with different intensities 
ranging from 40-75% of maximum oxygen consumption (VO2 max). Conversely, Quinn 
and colleagues (2000) report a greater hypotensive effect after a high intensity (75% VO2 
max) aerobic exercise bout in comparison to a bout performed at moderate intensity (50% 
VO2 max). 
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1.2.2 Effects of Chronic Aerobic Exercise on BP 
The effectiveness of chronic aerobic training in reducing resting BP is well 
established. The weight of evidence to date suggests that aerobic exercise interventions 
reduce resting BP on average of ~2/2 mmHg and ~7/5 mmHg in normotensives and 
hypertensives, respectively (Cornelissen et al., 2013; Cornelissen & Fagard, 2005). 
Numerous studies provide evidence to support the success of this form of training, even 
when employing a wide variety of training regimens with modalities including walking, 
running, or cycling and frequencies ranging from 1 to 7 days per week (Kelley et al., 
2001; Pescatello et al., 2004; Cornelissen & Fagard, 2005; Cornelissen et al., 2013). It is 
largely suggested in the literature that exercise intensity does not have a significant 
influence on post-training resting BP changes. However, some investigations report that 
moderate intensity training can produce a greater hypotensive response in comparison to 
high and low intensity (Pescatello et al., 2004; Cleroux et al., 1999).  
The mechanisms underlying the observed post-training resting BP reductions 
remain unclear. HT has a multifaceted etiology as noted above and, thus, several 
pathways are likely involved in the hypotensive adaptations to aerobic training. One 
meta-analysis concluded that chronic aerobic exercise reduces resting BP through a 
decrease in TPR rather than changes in Q (Pescatello et al., 2005). It is speculated that 
alterations in neural and hormonal factors may also lead to resting BP reductions 
following training. Aerobic training may also induce reductions in SNS activity, thereby 
reducing circulating levels of NE, a potent vasoconstrictor, leading to decreases in BP 
(Pescatello et al., 2005). Moreover, it is believed genetics may play a role in 
responsiveness to aerobic training; however, the mechanisms of this remain to be 
elucidated (Rice et al., 2002). 
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Although the positive effects of chronic aerobic exercise on resting BP are well 
establshed, the influence of this form of training on ambulatory BP is under-investigated. 
A growing body of evidence suggests that aerobic training can significantly decrease 
ambulatory BP in both normotensive and hypertensive individuals (Cornelissen et al., 
2013; Cornelissen &Fagard, 2005). The evidence to date suggests that aerobic exercise 
interventions can result in significant reductions in daytime ambulatory BP of ~3/3 
mmHg in normotensives, and although more variable in hypertensives, significant 
reductions in daytime ambulatory BP between 3-12/3-7 mmHg have been noted (Cardoso 
et al, 2010; Cornelissen et al, 2013). 
1.2.3 Acute Effects of Resistance Exercise on BP 
 
Participating in an acute resistance exercise bout induces sudden and 
simultaneous increases in systolic BP and diastolic BP up to 400/200 mmHg 
(MacDougall et al., 1985).  The nature of the response can be attributed to the high 
intramuscular pressure associated with the movement and the ensuing compression 
experienced by the vasculature. The net result is dramatic increases to TPR as well as 
occlusion of blood flow to the working muscles. In an effort to restore perfusion, SNS 
activity increases, leading to increases in both HR and BP (Mayo et al., 1999). The extent 
of this response is proportional to the work performed by the contracting muscle 
(MacDougall et al., 1985).   
Numerous studies have investigated the effects of resistance exercise on resting 
BP. Several have verified a significant PEH effect while others have not (Cardoso et al., 
2010).  In a population of hypertensives, Melo and colleagues (2006) studied the effects 
of an acute resistance exercise circuit involving 6 exercises targeting all major muscle 
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groups (3 sets, 20 repetitions, 40% of 1 repetition maximum; 1RM). Researchers verified 
a significant decrease in both systolic BP and diastolic BP for 10 hours post-exercise. 
Conversely, Hardy and Tucker (1998) found a PEH effect only persisting 1 hour, also in 
a population of hypertensives, using a protocol of a higher intensity (7 exercises, 3 sets, 
8-12 repetitions or to fatigue). Observations from several studies suggest that low-
intensity acute resistance exercise might have a stronger hypotensive effect than high-
intensity exercise (Cardoso et al., 2010; Hardy and Tucker et al., 1998; Melo et al., 1998). 
However, it is hypothesized that the PEH effect observed in acute resistance exercise 
interventions can simply be explained by reperfusion of previously occluded working 
muscles (MacDonald, 2002).  
Data regarding ambulatory BP and acute resistance exercise remains scarce 
(Cardoso et al., 2010). A recent study by Sher and colleagues (2011) investigated the 
effect of different volumes of acute resistance exercise in a population of mediated 
hypertensives. The study revealed that only the highest volume exercise session (40 
minutes, 10 exercises, 1 circuit, 20 repetitions, 40% 1RM) promoted a reduction of 
systolic ambulatory BP, while the lower volume protocol, which used the same protocol 
but half the duration (20 minutes, 10 exercises, 20 repetitions, 40% 1RM), did not. The 
results of this investigation suggest that employing a low intensity, high volume 
resistance exercise session can result in a greater persisting PEH (Sher et al., 2011). 
1.2.4 Effects of Chronic Dynamic Resistance Exercise on BP 
 
The literature encompassing resistance training and its influence on resting BP in 
individuals with and without HT is less comprehensive than that of aerobic training 
(Cardoso et al., 2010). In a meta-analysis involving both hypertensive and normotensive 
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participants, dynamic resistance training was shown to reduce BP on average of 4/2 
mmHg and 4/4 mmHg in hypertensives and normotensives, respectively (Cornelissen et 
al., 2011). The training protocols examined varied tremendously (6-26 weeks, 2-3 
sessions per week, 1-14 exercises, 1-4 sets, 1-25 repetitions, with intensity of 30-90% 
1RM) (Cornelissen et al., 2011; Cornelissen & Fagard, 2005). In regards to ambulatory 
BP, only two studies have investigated the effect of dynamic resistance training on this 
measure. Bluementhal and colleagues (1991) investigated a population of hypertensives 
and employed a training protocol involving a 30 minute training circuit, 2-3 times per 
week for 16 weeks. Van Hoof and colleagues (1996) looked at participants with and 
without HT using a training program lasting16 weeks with 3 sessions per week (3 sets of 
10 exercises, 4-12 repetitions, 70-90% 1RM). The outcome of both studies did not verify 
any significant change in post-training ambulatory BP in either population (Bluementhal 
et al., 1991; Van Hoof et al., 1996). There is no strong evidence to suggest that dyanamic 
resistance training is effective in lowering ambulatory BP, but taking into consideration 
the dearth of studies revolving around the issue, generating a conclusion on the efficacy 
of this form of training may be premature. 
 
1.3 Effects of Isometric Resistance Exercise on BP 
 
Despite the emphasis placed on physical activity in prevention and management 
of HT it appears that only 15% of individuals in Canada are meeting the exercise 
guidelines (Colley et al., 2011). This presents as a major public health challenge and 
requires investigation into more efficient and novel forms of exercise. Over the past 
decade, isometric resistance exercise, which involves sustained contractions with no 
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change in length of the working muscle groups, has garnered much attention from the 
research community (Carlson et al., 2014; Millar et al., 2014; Brook et al., 2013, 2015), 
and as mentioned in Section 1.1.8, is now recommended by the AHA as an efficacious 
treatment for HT. 
IHG exercise, the more studied form of isometric exercise and the version 
recommended by the AHA requires the use of a handgrip dynamometer (Brook et al., 
2013). As mentioned above in Section 1.1.8, participants perform multiple, timed, 
continuous contractions at a set percentage of their MVC (Brook et al., 2013; Wiley et 
al., 1992). A lesser studied form of isometric exercise, but one that appears to elicit 
similar benefits, is isometric leg (IL) exercise. This exercise modality involves the use of 
an isokinetic dynamometer with an extended leg attachment to enable single or double 
leg extensions. Participants sit in an upright position with a 90 degree flexion of the hip 
and perform multiple, timed continuous leg extensions at a set percentage of their MVC 
(Brook et al., 2013; Baross et al., 2012; Devereux et al., 2010). 
1.3.1 Acute Effects of Isometric Exercise on BP 
 
An acute bout of isometric exercise results in a mechanical compression of the 
vasculature supplying the working muscle. To compensate for reductions in blood flow, 
sensory receptors induce a pressor reflex triggering increases in SNS activity, leading to 
immediate increases in HR and Q (Mark et al., 1985; Mayo et al., 1999). 
The effect of acute IHG exercise on PEH and the mechanisms underlying the 
responses are understudied. Millar and colleagues (2009) observed PEH following IHG 
exercise in healthy, older participants. The acute IHG bout consisted of 4, 2 minute 
bilateral contraction at 30% MVC and resulted in a significant reduction in systolic BP of 
25 
 
3 mmHg. In normotensive, younger individuals, there is evidence to suggest that acute 
IHG protocols reduce BP by ~12/11 mmHg (Araujo, 2011; Millar, 2010). This response 
may or may not be governed by the same mechanisms regulating the effects of chronic 
IHG exercise. Further development in this area may help provide insight into the 
mechanism(s) which regulate(s) chronic IHG exercise adaptations.  
With respect to the effect of acute IL exercise on PEH, currently there is no 
information published in the literature and is, thus, an area that requires investigation. 
1.3.2 Effects of Chronic Isometric Exercise on BP 
 
Numerous studies have explored the benefits of IHG training and have reported 
marked reductions in resting systolic BP and diastolic BP in men and women, with and 
without HT, including medicated hypertensive patients, and regular exercisers. The 
positive outcomes of these studies used a diversity of interventional strategies. The 
protocols employed range from 3 to 5 sessions per week, with durations of 45 second to 2 
minute contraction times, intensities of 30 to 50% of MVC, and training lengths of 5 to 
10 weeks.  The described studies provide compelling evidence of the resting BP lowering 
effects of IHG training (Carlson et al., 2014; Millar et al., 2014; Badrov et al., 2013a; 
Badrov et al., 2013b; McGowan et al., 2006; McGowan et al., 2007a; McGowan et al., 
2007b; Millar et al., 2007, Millar et al., 2008; Peters et al., 2006; Taylor et al., 2003; 
Wiley et al., 1992; Ray & Carrasco, 2000).  Meta-analyses involving normotensive, pre 
hypertensive, and hypertensive individuals revealed the efficacy of IHG training in 
reducing systolic BP by 10- 13 mmHg and diastolic BP by 6- 8 mmHg (Millar et al., 
2014).  
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Lesser studied are the effects of IL training on resting BP. In a recent study, 
Devereux and colleagues (2010) demonstrated that, in a normotensive population, 
bilateral IL training can significantly reduce both systolic BP (5 mmHg) and diastolic BP 
(3 mmHg). The training spanned over 4 weeks, 3 times per week and the protocol 
involved 4 bouts of 2 minute sustained leg extensions at 24% of MVC, separated by 3 
minutes of rest (Devereux et al., 2010). Using a similar protocol, Wiley and colleagues 
(2010) compared the effect of two different exercise intensities (high and low intensity; 
10 and 20% MVC, respectively) in a young, normotensive population. Following 8 
weeks of training, significant reductions in systolic BP and diastolic BP were observed in 
both training groups. The BP-lowering effect of high intensity IL training (5/3 mmHg) 
was slightly greater than low intensity IL training (4/3 mmHg), however, not statistically 
significant (Wiley et al., 2010). IL training in the hypertensive population has not been 
examined and could provide support as a management strategy for HT. 
A recent meta-analysis was performed on the collective isometric exercise 
interventions (including IHG and IL training) lasting 4 or more weeks and involving 
participants with and without HT. This work revealed significant mean reductions in 
systolic BP by 4 mmHg and 8 mmHg in hypertensives and normotensives, respectively. 
Additionally, reductions in diastolic BP by 5 mmHg and 3 mmHg were noted in 
hypertensives and normotensives, respectively (Carlson et al., 2014). However, there 
appears to be significant inter-individual variability in the responsiveness of resting BP to 
the IHG training intervention. For example, Millar and colleagues (2008) observed that 
individuals with higher pre-training resting BP values experienced greater reductions 
following IHG training. Furthermore, it appears post-menopausal normotensive women 
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are more responsive to IHG training than age-matched normotensive men, as indicated by 
greater post-training reductions in resting BP (Millar et al., 2008). In contrast, data from 
our laboratory (Physical Activity and Cardiovascular Research Laboratory; PACR 
Laboratory, Department of Kinesiology, University of Windsor) suggest IHG training is 
equally effective at reducing resting BP in young, normotensive men and women (Hanik 
et al., 2012). 
Exploration into the effects of isometric exercise training (IHG or IL) on 
ambulatory BP is under-investigated.  A study conducted from our research group 
(PACR Laboratory, Department of Kinesiology, University of Windsor) looked at a 
population of well-controlled medicated hypertensive patients. Participants performed 4, 
2 minute bilateral IHG contractions at 30% MVC, 3 times per week for 8 weeks (Stiller-
Moldovan et al., 2012). Stiller-Moldovan and colleagues (2012) reported no statistically 
significant changes in ambulatory BP following the 8 week IHG training intervention. 
Importantly, however, clinically relevant reductions in mean 24-hr and nighttime SBP 
(~3 and ~4 mmHg, respectively) were noted. A limitation to the study was the use of a 
population of medicated, well-controlled hypertensives which may have blunted response 
to IHG training, and thus further investigation in different populations and/or different 
interventional lengths is warranted. Investigations into the effect of IL training on 
ambulatory BP have yet to be performed. 
Although the hypotensive effects of IHG training on resting BP are well 
established, the associated mechanisms have yet to be fully elucidated. Hypotensive 
adaptations likely involve a complex synergy of mechanisms encompassing modulation 
of the ANS, improved endothelium-dependent vasodilation, and/or reductions in 
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oxidative stress function (McGowan et al., 2006; McGowan et al., 2007a; McGowan et 
al., 2007b; Millar et al., 2009; Millar et al., 2014) , and differ based on population 
characteristics.  
1.4 Cardiovascular Reactivity 
 
As mentioned in Section 1.3, there appears to be high inter-individual variability 
in responsiveness to IHG training. One method of exploring these differences is to assess 
the cardiovascular reactivity response (arterial BP and HR) to psychophysiological 
stressors. Cardiovascular reactivity refers to the magnitude of the difference observed 
between peak arterial BP and HR during exposure to the stressor and the same measures 
at baseline (Gerin et al., 2000). The cardiovascular reactivity hypothesis proposes that 
acute BP elevations occurring during the presentation of stressors can lead, over time, to 
chronic elevations in resting BP and subsequent development of primary HT (Gerin et al., 
2000). Thus, reactivity can predict risk of HT as well as, in recent observations, 
responsiveness to IHG training (Millar et al., 2009; Badrov et al., 2013a). 
Commonly used laboratory stressors include the serial subtraction task (SST; 
imposing a mental stress), IHG task (IHGT; a physiological stressor), and the cold-
pressor task (CPT; a physiological stressor). An example of a commonly used SST 
involves participants mentally subtracting a 2 digit number from a series of 4 digit 
numbers displayed for a set period of time (i.e. 5 seconds). The participant must respond 
to the question before the appearance of the next number (Badrov et al., 2013a; Millar et 
al., 2009). Increases in BP during the SST are through increases in Q via the β-adrenergic 
system (Millar et al., 2009). An example of an IHGT, employed by Badrov et al (2013a), 
involves a 2 minute sustained IHG contraction at 30% of MVC using the non-dominant 
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arm. Similar to the SST, observed increases in BP are through increases in Q by 
modulation of the β-adrenergic system (Badrov et al., 2010). The CPT involves 
immersion of a peripheral limb (hand or foot) in ~4±1° C cold water bath for 2-10 
minutes (Badrov et al., 2013a; Millar et al., 2009). In contrast to the SST and IHGT, 
increases in BP during this task is mediated through α-adrenergic vasoconstriction 
resulting in increases to TPR and is thus classified as a vascular mediated BP response 
(Badrov et al., 2010). Because the increases in BP during the CPT task are not 
myocardial in nature, the task effectively acts as a control.  
Work by Millar and colleagues (2009) demonstrated that cardiovascular reactivity 
to a SST, but not a CPT, is predictive of IHG training success in older, normotensive 
participants who trained 3 days per week for 8 weeks (4, 2 minute bilateral contractions 
at 30% MVC). Similarly, in a recent study conducted by Badrov and colleagues (2013a), 
it was found that systolic BP reactivity to a SST and IHGT, but not to a CPT was 
predictive of responsiveness to IHG training (10 weeks, 3 times per week, 4, 2 minute 
bilateral contractions at 30% MVC) in individuals with HT. Participants who elicited the 
highest pre-training reactivity had the greatest reductions in systolic BP following 10 
weeks of IHG training. Badrov and colleagues (2013a) also provided the first evidence 
that IHG training can attenuate cardiovascular reactivity. In particular, systolic BP 
reactivity to a SST and IHGT, but not a CPT was attenuated post-IHG training (Badrov et 
al., 2013a).  
The association between BP and HR reactivity to psychophysiological stressors in 
predicting IHG post-training reductions in resting and ambulatory BP in the young, 
normotensive population as well as whether sex differences exist in responsiveness to 
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training has yet to be explored. Understanding this association in young, healthy 
individuals could provide useful information for recommendations of primary prevention 
strategies for HT. 
 
1.5 Thesis Objectives and Hypotheses  
 
The current investigation aimed to increase our understanding of the effects of 
IHG training on BP, and who responds best to this novel intervention. Furthermore, 
understanding sex differences in predicting responsiveness to IHG training is 
fundamental in primary prevention of HT as it has many implications in relation to 
exercise prescription. 
More specifically, the purpose of the current investigation was three-fold: 1) To 
explore the efficacy of IHG training in concomitantly reducing resting and ambulatory 
BP, 2) to determine if systolic BP reactivity to an IHGT and SST could predict IHG-
training induced reductions in resting BP as observed in a prospective analysis by Badrov 
and colleagues (2013a) in hypertensive participants, and the novel measure ambulatory 
BP and lastly, 3) to investigate if the IHG exercise intervention could attenuate stress 
task-induced reactivity. The present study also aimed to examine the differences and/or 
parallels observed between men and women with respect to the aforementioned 
objectives in order to address the paucity of information in this area. Ultimately, 
understanding sex differences can provide more definitive strategies for primary 
prevention of HT for young, men and women. 
It was hypothesized that both men and women would experience reductions in 
resting and ambulatory BP following 10 weeks of IHG training based on observations in 
previous work investigating young, normotensives (Hanik et al., 2012). It was further 
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hypothesized that systolic BP reactivity to an IHGT and SST, but not a CPT, would be 
predictive of IHG responsiveness, such that participants who responded to the SST and 
IHGT with the greatest increases in systolic BP would experience the greatest reductions 
in BP and ambulatory BP following IHG training (Badrov et al, 2013a; Millar et al., 
2009).  Furthermore, it was hypothesized that IHG training would attenuate systolic BP 
reactivity in both men and women as observed by Badrov and colleages (2013a) in 
hypertensive participants. 
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The effect of a 10 week isometric handgrip training protocol on blood pressure 
(resting and ambulatory) and cardiovascular reactivity in young, normotensive 
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2.1 Introduction  
 
As our population ages, expands, and globalizes, disease patterns are 
fundamentally shifting and non-communicable diseases, like cardiovascular disease 
(CVD), are becoming more prevalent (Smith et al., 2012). Presently, CVD is the leading 
cause of morbidity and mortality in Canada and worldwide (WHO, 2013). Hypertension 
(HT), a condition characterized by sustained elevations in arterial blood pressure (BP), is 
a major risk factor for CVD related events such as coronary heart disease and stroke 
(WHO, 2013). Complications of HT account for 9.4 million deaths worldwide every year 
and, thus, pose a considerable economic burden on global healthcare (WHO, 2013). In 
Canada, HT afflicts over 6 million individuals, representing a significant economic 
burden to the Canadian health care system (Robitaille et al., 2011; Public Health Canada, 
2009). The World Health Organization (WHO) has identified HT as a global health crisis 
and predicts an epidemic of HT in the near future. In light of this, the WHO has now 
focused their efforts on primary prevention of HT (WHO, 2013). 
Individuals diagnosed with HT have a resting arterial BP ≥ 140/90mmHg 
(systolic BP /diastolic BP) and/or are on anti-hypertensive medication (Chobanian et al., 
2003). A diagnosis of pre-hypertension (120-139/80-89 mmHg) can also increase the risk 
of future CVD development (Hsia et al., 2007; Liszka et al., 2005). Recently, ambulatory 
BP, a measure that provides insight into 24-hour fluctuations in BP, has been found to be 
a better predictor of CVD risk than conventional, in-clinic resting BP measurements 
(Hansen et al., 2010; Pickering et al., 2006). Typically, ambulatory BP is monitored 
every 15-30 minutes throughout the daytime period (6 a.m. – 10 p.m.) and every hour 
throughout the nighttime period (10 p.m. – 6 a.m.), generating a mean 24-hour, daytime, 
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and nighttime ambulatory measure of systolic and diastolic BP (Pickering et al., 2006; 
Stiller-Moldovan et al., 2012). Individuals who have a mean 24-hour ambulatory BP > 
130/80 mmHg and/or a daytime ambulatory BP > 135/85 mmHg for systolic BP and 
diastolic BP, respectively, are considered for a diagnosis of HT (Pickering et al., 2006). 
Normotensive counterparts have a diurnal rhythm of BP where BP falls 10 – 20% during 
the nighttime period (Pickering et al., 2006). In patients with HT, this nocturnal fall in BP 
is often diminished (<10%), and appears to cause an increased risk for CVD development 
(Pickering et al., 2006). Thus, nighttime ambulatory BP has been identified as a more 
accurate predictor of CVD risk (O’Brien et al., 2003; O’Brien et al., 2007; Cohen & 
Townsend, 2010).   
It is posited that the development of HT can be attributed to a combination of 
factors including but not limited to genetics, lifestyle, sex, and age (Rice et al., 2002; 
Chobanian et al., 2003). Current guidelines for prevention and management of HT advise 
the adoption of a number of lifestyle modifications, (Blumenthal et al., 2010; Sacks et al., 
2001), of which exercise is an integral component (Thompson, 2014). The weight of 
evidence suggests that aerobic exercise interventions reduce resting BP an average of 2/2 
mmHg and 7/5 mmHg in normotensives and hypertensives, respectively. While 
somewhat more equivocal, dynamic resistance interventions reductions are reported to be 
~4/4 mmHg and 4/2 mmHg in normotensives and hypertensives, respectively 
(Cornelissen et al., 2013; Cornelissen et al, 2011). The impact of both aerobic and 
dynamic resistance exercise on ambulatory BP has been less studied, yet the evidence to 
date suggests that aerobic exercise interventions can result in significant reductions in 
daytime ambulatory BP (6 a.m. – 10 p.m.) by 3/3 mmHg in normotensives, and although 
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more variable in hypertensives, significant reductions in daytime ambulatory BP between 
3-12/3-7 mmHg have been noted (Cardoso et al, 2010; Cornelissen et al, 2013). To date, 
only two studies have investigated the effects of dynamic resistance exercise training 
interventions on ambulatory BP in either hypertensive or normotensive participants, and 
neither observed post-training reductions in ambulatory BP (Blumenthal et al., 1991; Van 
Hoof et al., 1996).   
Despite the clear benefits of exercise in the prevention and management of HT, a 
recent report suggests that only 15% of Canadians are meeting the recommendations for 
physical activity (Colley et al., 2011). Such poor adherence necessitates the need for a 
more efficient yet effective form of exercise, as either a stand-alone or an adjunct to 
traditional exercise training programs.  
Isometric handgrip (IHG) training, a form of resistance exercise involving 
multiple timed sustained (static) contractions performed at a set percentage of maximum 
voluntary contraction (MVC) on a programmed handgrip dynamometer, was recently 
endorsed by the American Heart Association (AHA) as an alternative BP-lowering 
treatment (Brook et al., 2015; Brook et al., 2013). This recommendation was founded in 
the accumulating evidence of the effectiveness of IHG training in reducing resting BP in 
both men and women with and without HT, including those medicated for HT and those 
who exercise regularly (Carlson et al., 2014; Millar et al., 2014; Badrov et al., 2013a; 
Badrov et al., 2013b; McGowan et al., 2006; McGowan et al., 2007a; McGowan et al., 
2007b; Millar et al., 2007, Millar et al., 2008; Peters et al., 2006; Taylor et al., 2003; 
Wiley et al., 1992; Ray & Carrasco, 2000). The IHG protocols employed in these studies 
were diverse, ranging from 3 to 5 sessions per week, with durations of 45 second to 2 
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minute contraction times, intensities of 30 to 50% of MVC, and training lengths from 5 to 
10 weeks (Millar et al., 2014; Badrov et al., 2013a; Badrov et al., 2013b; McGowan et al., 
2006; McGowan et al., 2007a; McGowan et al., 2007b; Millar et al., 2007, Millar et al., 
2008; Peters et al., 2006; Taylor et al., 2003; Wiley et al., 1992; Ray &Carrasco, 2000). 
However, the most studied protocol consists of: an 8 week interventional training length 
involving 4, 2 minute sustained bilateral contractions performed at 30% of MVC, 
performed 3 times per week (Millar 2014; McGowan et al., 2007a; Millar et al., 2008; 
Stiller-Moldovan et al., 2012; Badrov et al., 2013b).   
In the only published study to date on the effects of IHG training on ambulatory 
BP, Stiller-Moldovan and colleagues (2012) found that an IHG training protocol 
involving 4, 2 minute bilateral IHG contractions at 30% MVC, 3 times per week for 8 
weeks resulted in clinically relevant reductions in mean 24-hour (~3 mmHg; average of 
24 hour fluctuations in BP) and nighttime systolic BP (~4 mmHg; measured from 10 p.m. 
– 6 a.m.) in a population of well-controlled medicated HT patients (mean ± SD, resting 
BP: 114 ± 13/61 ± 12 mmHg).  Although not statistically significant, these minor 
reductions were clinically significant in that they may potentially reduce CVD risk 
(Pescatello et al., 2004). Given the recent evidence supporting its superiority in predicting 
CVD risk, the effects of aerobic and resistance training (dynamic and isometric) on 
ambulatory BP warrant further investigation (O’Brien et al., 2003; Pickering et al., 2006; 
O’Brien et al., 2007; Cardoso et al.,2010). 
The underlying mechanisms responsible for the observed reductions in BP with 
IHG training remain equivocal. The BP lowering effects of aerobic training have been 
attributed to reductions in total peripheral resistance (TPR) while in dynamic resistance 
46 
 
training the mechanisms responsible for BP reductions are speculated to be similar, as 
training minimally alters cardiac output (Q) (Pescatello et al., 2004). The weight of the 
evidence suggests that improvements in resting BP in response to IHG training may be 
attributed to enhanced autonomic modulation, improved endothelium-dependent 
vasodilation, and/or reductions in oxidative stress (McGowan et al., 2006; McGowan et 
al., 2007a; McGowan et al., 2007b; Millar et al., 2009; Badrov et al., 2013b). It is 
possible that a variety of mechanisms work in concert, and differ based on population 
characteristics. 
The efficacy of IHG training in reducing resting BP is evident but there appears to 
be significant inter-individual variability in responsiveness to training. Millar and 
colleagues (2008) observed that participants with higher pre-training resting BP values 
experienced greater reductions following training. Furthermore, it appears post-
menopausal normotensive women are more responsive to IHG training than age-matched 
normotensive men, as indicated by greater post-training reductions in resting BP (Millar 
et al., 2008). In contrast, preliminary data from Hanik and colleagues (2012) suggest IHG 
training is equally effective at reducing resting BP in young, normotensive men and 
women. The reason(s) for these discrepant responses is/are unclear and warrant further 
exploration to elucidate the differences between men and women. 
Cardiovascular reactivity, an individual’s acute BP and heart rate (HR) response 
to a physical or mental stressor, is a reliable predictor of IHG responsiveness (Carrol et 
al., 2012). For example, work by Millar and colleagues (2009) demonstrated, using a 
retrospective design, that BP and HR reactivity to a serial subtraction task (SST; a math 
task involving subtracting a 2 digit number from a series of numbers) but not a cold 
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pressor task (CPT; a two minute hand immersion in a cold water bath) was predictive of 
reductions in resting systolic BP in older, normotensive individuals who trained 3 days 
per week for 8 weeks (4, 2 minute bilateral contractions at 30% MVC). This work 
suggests IHG training attenuations in systolic BP are myocardial mediated as the CPT 
mediates increases in BP peripherally via increases in TPR (Millar et al., 2009). 
Similarly, using a prospective design, Badrov and colleagues (2013a) recently 
demonstrated that systolic BP reactivity to both a SST and IHG task (IHGT; a 2 minute 
isometric contraction at 30% MVC on a handgrip dynamometer), but not to a CPT, was 
predictive of responsiveness to IHG training in hypertensive participants such that 
individuals in the study who elicited the highest pre-training reactivity had the greatest 
reductions in systolic BP following 10 weeks of IHG training. Badrov and colleagues 
(2013a) also provided the first evidence that IHG training (10 weeks, 3 times per week, 4, 
2 minute bilateral contractions at 30% MVC) can attenuate systolic BP reactivity to a 
SST and IHGT in hypertensive subjects. Importantly, no changes in measures of state or 
trait anxiety from pre-post training were found.  This is clinically important as high 
cardiovascular reactivity is associated with future development of CVD (Carrol et al., 
2012). The association between BP reactivity to psychophysiological stressors and IHG-
training BP reductions in a young, normotensive men and women, and whether sex 
differences exist, has yet to be explored. Understanding these differences is pertinent to 
the priority efforts of the WHO. With the WHO emphasis on primary prevention, this 
work may add to our understanding of effective exercise interventions to regulate blood 
pressure in young men and women.  
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2.2 Purpose and Hypotheses 
 
The current investigation aimed to increase our understanding of the effects of 
IHG training on BP, and who responds best to this novel intervention. Furthermore, 
understanding sex differences in predicting responsiveness to IHG training is 
fundamental in primary prevention of HT as it has many implications in relation to 
exercise prescription. 
More specifically, the purpose of the current investigation was three-fold: 1) To 
explore the efficacy of IHG training in concomitantly reducing resting and ambulatory 
BP, 2) to determine if systolic BP reactivity to an IHGT and SST could predict IHG-
training induced reductions in resting BP as observed in a prospective analysis by Badrov 
and colleagues (2013a) in hypertensive participants, and the novel measure ambulatory 
BP and lastly, 3) to investigate if the IHG exercise intervention could attenuate stress 
task-induced reactivity. The present study also aimed to examine the differences and/or 
parallels observed between men and women with respect to the aforementioned 
objectives in order to address the paucity of information in this area. Ultimately, 
understanding sex differences can provide more definitive strategies for primary 
prevention of HT for young, men and women. 
It was hypothesized that both men and women would experience reductions in 
resting and ambulatory BP following 10 weeks of IHG training based on observations in 
previous work investigating young, normotensives (Hanik et al., 2012). It was further 
hypothesized that systolic BP reactivity to an IHGT and SST, but not a CPT, would be 
predictive of IHG responsiveness, such that participants who responded to the SST and 
IHGT with the greatest increases in systolic BP would experience the greatest reductions 
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in BP and ambulatory BP following IHG training (Badrov et al, 2013a; Millar et al., 
2009).  Furthermore, it was hypothesized that IHG training would attenuate systolic BP 
reactivity in both men and women as observed by Badrov and colleages (2013a) in 
hypertensive participants. 
2.3 Methods 
 
Study Participants 
Thirty-one young (18-40 years of age), normotensive men (n=16; Age: 25 ± 3 
years; Resting BP: 115 ± 5/63 ± 4 mmHg, X ± standard deviation, SD) and women 
(n=15; Age: 24 ± 5 years; Resting BP: 104 ± 4/62 ± 3mmHg, X ± standard deviation, 
SD) were recruited from Windsor, ON and surrounding community (Appendix A) and 
enrolled in the protocol. Exclusion criteria for the study included the presence of 
disorders (e.g., hypertension) and/or prescribed pharmacotherapies (e.g., beta-blockers) 
known to influence neurovascular function, and/or physical limitations impairing exercise 
performance. This study was cleared by the University of Windsor Research Ethics 
Board (REB# 13-106). 
Study Design 
Eligibility and Familiarization: 
Visit 1 
Individuals whom expressed interest in participating met with the study 
investigators in the Physical Activity and Cardiovascular Research (PACR) Laboratory 
(Room #240, Human Kinetics Building, University of Windsor, Windsor, Ontario, 
Canada). Participants read a consent form (Appendix D) and information sheet 
(Appendix E) related to the study. The study investigators explained all parts of the 
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investigation to the potential participants and those whom were still interested in taking 
part in the study signed the consent form (Appendix D). Once written informed consent 
was obtained, a medical history was attained using a brief medical questionnaire 
(Appendix F). Participants had their resting BP measured to ensure that they met the 
inclusion criteria for normotension (resting BP < 140/90 mmHg). Resting BP (dominant 
arm) and HR were measured according to standard laboratory protocols using brachial 
artery oscillometry (Appendix G; Dinamap Carescape v100,Critikon, Tampa, Florida, 
USA) (Badrov et al., 2013a; Badrov et al., 2013b; Stiller-Moldovan et al., 2012). In brief, 
following 10-minutes of seated rest, BP and HR were measured 4 times, with a 2-minute 
rest period between measures, and the last 3 values were then averaged. Any questions or 
concerns regarding the study were answered, and participants were informed of their 
right to withdraw from the study at any time. 
Visit 2 
At least 24-hours following Visit 1 participants returned to the PACR Laboratory. 
First, participants had their resting BP measured in the same manner as described above 
(see section: Visit 1). If average resting arterial BP values from Visit 1 and Visit 2 were < 
140/90 mmHg, participants were eligible to continue. All eligible participants completed 
a familiarization session to habituate themselves to the investigative procedures, 
minimize the effects of anxiety and unfamiliarity on study variables, and allow the 
opportunity to practice all portions of the investigation.  
Following familiarization, participants completed a physical activity readiness 
questionnaire (PAR-Q; Appendix H). All participants received two letters (Appendix I) 
that were taken to their health care provider. The first letter notified their health care 
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provider of the participant’s involvement in the study. The second letter was signed by 
the health care provider and returned to the study investigators in acknowledgement of 
the participant’s involvement in the study. 
Testing 
After receipt of the signed health care provider documents by investigators 
(Appendix I), tests were conducted to assess resting BP and cardiovascular reactivity to 
an IHGT, SST and CPT. All tests took place at the same time of day (within 2 hours), in a 
quiet, temperature-controlled room (range: 20-23°C), following a light meal, 24-hour 
abstinence from alcohol consumption and vigorous physical activity, and a 12-hour 
abstinence from caffeine (Badrov et al., 2013a). Participants voided their bladder prior to 
the testing session (Fagius & Karhuvaara, 1989). Baseline testing was repeated following 
10-weeks of IHG training (week 11), at least 48 hours following the last IHG training 
session. Please see Figure 1 for a schematic diagram of the study design. 
Testing Day 1:  
Resting BP and HR: Resting BP and HR were measured in the same manner as per 
Visits 1 and 2.  Following this, participants performed three cardiovascular stress 
reactivity tasks in random order. During each stress task, BP and HR were measured 
every minute via brachial artery oscillometry. Beat-to-beat HR was continuously 
collected via single-lead electrocardiography (Appendix J; AD instruments, Colorado 
Springs, Colorado, USA) using a data acquisition system (Appendix K; Powerlab ML 
870/P, AD instruments, Colorado Springs, Colorado, USA). HR and BP were monitored 
for at least 10 minutes following the completion of each task to ensure values stabilized 
to baseline levels. 
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Serial Subtraction Task (SST): All participants viewed a computer monitor displaying 
a 4-digit number and were asked to mentally subtract a 2-digit number (e.g., 13 at pre-
testing, 17 at post-testing) from the number displayed and respond with their answers 
aloud prior to the appearance of the next number. Participants were shown 25 numbers in 
total where each number was displayed for 5 seconds, and participants responded within 
that time frame with his or her answer for each number. The number of correct and 
incorrect responses were recorded by the investigator (Badrov et al., 2013a). 
Isometric Handgrip Task (IHGT): Participants performed a single 2-minute sustained 
isometric contraction at 30% of their MVC with the non-dominant hand on a 
programmed handgrip dynamometer (Appendix L; ZonaPLUS, Zona HEALTH, Boise, 
Idaho, USA; Badrov et al., 2013a). MVC was determined prior to contraction via 
electronic linear load cells contained within the IHG device. The IHGT protocol was 
identical pre-and post-testing, and participants maintained a compliance score of 95% (% 
participants maintained 30% MVC). 
Cold Pressor Task (CPT): Participants immersed their right hand (up to the wrist) in a 
temperature-controlled cold-water bath (4 ± 1°C) for 2 minutes (Badrov et al., 2013a). 
The CPT was well tolerated as evidenced by all participants completing the task at both 
pre- and post-testing time points. 
Ambulatory Blood Pressure: At the completion of the laboratory testing session, 
ambulatory BP was monitored for 24-hours (Appendix M; SpaceLabs 90207 Ambulatory 
Blood Pressure Monitor, SpaceLabs Inc., Redmond, Washington, USA) (Stiller-
Moldovan et al., 2012). Daytime (6 a.m. to 10 p.m.) BP and HR were recorded two times 
per hour, and nighttime (10 p.m. to 6 a.m.) BP and HR were recorded one time per hour 
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over the 24-hour period. Values for the 24 hour period were averaged (mean 24-hour 
ambulatory BP) as well as during each time period (daytime and nighttime) (Stiller-
Moldovan et al., 2012). Following the completion of baseline ambulatory BP monitoring, 
a detailed history of activities performed during this time was acquired. Participants were 
instructed to perform similar activities during post-testing data collection in order to 
standardize BP recordings. This was verified with the participants during detailed 
discussions following their 24-hour monitoring session.  
Training (Time per training session: ~ 30 minutes) 
All participants trained on-site 3X/week for 10 weeks using the bilateral IHG 
exercise protocol, which involved four, 2-minute isometric contractions, performed at 
30% of MVC, separated by a 1-minute rest period, for a total of 12-minutes (Appendix L; 
ZonaPLUS, Zona HEALTH, Boise, Idaho, USA). All training sessions were supervised 
by an exercise trainer, and exercise log books (Appendix N) were used to record date of 
completion, MVC scores, final compliance %, and any changes in diet, exercise or 
nutrition. Resting BP and HR were measured prior to the start of each training session 
following 10-minutes of seated rest (data not used for analysis). 
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Figure 1. Schematic representation of study design. SST= serial subtraction task; IHGT= 
isometric handgrip task; CPT= cold pressor task; IHG= isometric handgrip; BP= blood 
pressure; HR= heart rate; MVC= maximum voluntary contraction 
 
2.4 Statistics 
 
One way ANOVAs were performed on all baseline resting and ambulatory 
measures to examine initial differences between men and women. In order to assess the 
efficacy of IHG training in lowering BP in men and women, a two way repeated 
measures ANOVA was employed to examine resting systolic BP, diastolic BP, MAP 
(diastolic BP + 1/3 (systolic BP-diastolic BP)), ambulatory BP (mean 24-hour, daytime, 
and nighttime), resting and ambulatory HR, and pulse pressure (systolic BP-diastolic BP). 
To determine cardiovascular reactivity (systolic BP, diastolic BP, and HR 
responses) to the IHGT, SST, and CPT, the difference between the peak stress task value 
and mean baseline resting and ambulatory values were calculated (Jennings et al., 1992). 
The relationship between cardiovascular reactivity and IHG training adaptations was 
assessed using Pearson correlation coefficients. Residualized change scores in systolic 
BP were used for the analysis as baseline BP and change in BP post-training have proven 
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correlated effects (Llabre et al, 1991; Millar et al., 2007). This value was determined by 
regressing change in systolic BP following the intervention on pre-intervention systolic 
BP. The regression analysis was performed for both resting and ambulatory systolic BP.  
To assess whether cardiovascular reactivity to the IHGT, SST, and CPT was 
attenuated post-IHG training in either groups, a two way repeated measures ANOVA was 
employed. All data was analyzed using IBM SPSS Statistics 21 software (SPSS Inc., 
Chicago, Illinois, USA) and statistical significance was set at P≤0.05. All data are 
presented as X ± SD unless otherwise stated. 
2.5 Results  
 
Participant Baseline Characteristics 
 
Of the 31 participants enrolled in the study, five participants were excluded from 
data analysis due to poor adherence to the IHG training schedule (< 2 trainings/week; 
n=2, 1 man, 1 woman) and/or extenuating life events (n=3, 2 men, 1 woman). Using X ± 
SD from previous studies investigating the effects of IHG training (Badrov et al., 2013a; 
Millar et al., 2009); an assigned alpha of 0.05, a beta of 0.2, 12 men and 12 women 
provided sufficient power to detect statistical significance. Thus the final sample size of 
26 (n=13 men, n=13 women) satisfied these criteria.  
All 26 participants trained for 10 weeks and completed 30 IHG sessions. 
Compliance to the IHG protocol itself was 97%, and averaged 98% for men and 96% for 
women. No changes in exercise, diet, or medication occurred in either sex. Importantly, 
no adverse events were reported in response to either the testing or IHG training 
interventions.  
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Men and women did not significantly differ in age, BMI, resting and ambulatory DBP, or 
resting and ambulatory HR (all P>0.05). Conversely, height, weight, resting and 
ambulatory systolic BP at baseline measurements were significantly different between the 
two groups (P<0.05). Outcome variables were not influenced as the multilevel ANOVA 
employed accounted for these initial differences, and no interactions between men and 
women were observed (P>0.05). Refer to Table 1 for participant baseline characteristics.  
 
Table 1. Participant baseline characteristics  
      
Characteristics Women (n=13) Men (n=13) 
      
   
Age (years) 25 ± 5 24 ± 4 
Height (cm) 167 ± 9* 179 ± 8 
Weight (kg) 63 ± 11* 80 ± 14 
BMI (kg/m
2
) 23 ± 4 25 ± 4 
Resting systolic BP (mmHg) 103 ± 5* 117 ± 5 
Resting diastolic BP (mmHg) 62 ± 8 65 ± 7 
Resting HR (beats∙min-1) 69 ± 12   63 ± 8 
Baseline Ambulatory measures† 
24 hour systolic BP (mmHg) 
 
120 ± 4* 
 
131 ±5 
24 hour diastolic BP(mmHg) 70 ± 5 72 ± 8 
24 hour ambulatory HR(beats∙min-1) 73 ± 9 67 ± 7 
 
BMI, body mass index; BP, blood pressure; HR, heart rate. Values are mean ± SD; †of the 13 
women, 11 completed the ambulatory BP measurements; *Significantly different from men 
(P<0.05). 
 
 
Effects of IHG training on BP and HR 
Following 10 weeks of IHG training, significant reductions in resting systolic BP 
and pulse pressure were observed in both men and women (all P<0.05, see Figure 2), yet 
no interaction was observed for resting systolic BP (P=0.21) or pulse pressure (P=0.36) 
between the two groups. Conversely, resting diastolic BP, MAP, and HR remained 
unchanged in both men and women (all P >0.05, see Table 2).  
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Figure 2. Effects of 10-weeks of IHG training on (a) systolic BP, and (b) pulse pressure 
in women (n=13) and men (n=13). Values are mean ± SE. RM ANOVA;⁺Significantly 
different from men (P < 0.05); *Significantly different from pre- (P<0.05).  
 
Table 2.  Resting cardiovascular adaptations to IHG training 
 
 
Women (n=13) Men (n=13) 
Pre- Post- Pre- Post- 
Resting Diastolic BP (mmHg) 62 ± 8 61 ± 8 65 ± 7 65 ± 9 
MAP (mmHg) 75 ± 7⁺ 74 ± 7 82 ± 6 81 ± 7 
Resting HR (beats/minute) 69 ± 12 66 ± 11 63 ± 8 64 ± 8 
 
BP, blood pressure; HR, heart rate; MAP, mean arterial pressure. Values are mean ± SD; 
⁺Significantly different from men (P < 0.05); * Significantly different from pre- (P<0.05) 
 
 
Significant IHG training reductions in all measures of systolic ambulatory BP 
were observed in both men and women. Specifically, significant post-training reductions 
were noted in mean systolic 24-hour, daytime, and nighttime ambulatory periods in both 
sexes (see Figure 3). No interaction was observed for 24-hour (P=0.77), daytime 
(P=0.36), or nighttime systolic ambulatory BP (P=0.81) between men and women.  
Following training, 24 hour, daytime, and nighttime diastolic ambulatory BP as 
well as 24 hour, daytime, and nighttime ambulatory HR remained unchanged in both men 
and women (all P >0.05, see Table 3). 
* 
* 
* 
* 
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Figure 3. Effects of 10-weeks of IHG training on 24-hour, daytime, and nighttime 
systolic ambulatory BP in women (n=11) and men (n=13). Values are mean ± SE; RM 
ANOVA; ⁺Significantly different from men (P< 0.05)*Significantly different from pre- 
(P<0.001). 
 
Table 3.  Effects of IHG training on blood pressure (diastolic) and heart rate 
 
 
Women (n=13) Men (n=13) 
Pre- Post- Pre- Post- 
Diastolic Ambulatory BP (mmHg)     
24 hour ambulatory BP  70 ± 5 67 ± 5 72 ± 8 72 ± 7 
Daytime ambulatory BP 73 ± 5 71 ± 6 75 ± 9 75 ± 9 
Nighttime ambulatory BP  62 ± 6 60 ± 6 66 ± 9 66 ± 8 
 
Ambulatory HR (beats/minute) 
    
24 hour ambulatory HR 73 ± 9 72 ± 10 67 ± 8 67 ± 7 
Daytime ambulatory HR 76 ± 9 75 ± 9 69 ± 8 69 ± 7 
Nighttime ambulatory HR 69 ± 9 67 ± 12 63 ± 8 64 ± 9 
 
BP, blood pressure; HR, Heart rate. Values are mean ± SD; RM ANOVA (all P >0.05) 
 
 
 
Cardiovascular Reactivity as a Predictor of IHG Training Effectiveness 
 
Cardiovascular stress reactivity responses to the IHGT, SST, and CPT at baseline 
and the relationship to IHG training effects on resting BP and heart rate are displayed in 
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Table 4. Men had a significantly higher SBP reactivity to the IHGT and SST than women 
(P<0.05). Significant IHG training induced reductions in resting systolic BP were 
associated with systolic BP reactivity to the IHGT (Figure 4a, P<0.05), but not the SST 
(Figure 4b) or CPT (Figure 4c) in both men and women (P<0.05). No associations were 
observed between diastolic BP and HR reactivity to the IHGT, SST, and CPT and 
residualized changes in systolic BP (P>0.05). Furthermore, no association was observed 
between all measures of cardiovascular reactivity to the IHGT, SST, and CPT and 
training-induced reductions in 24-hour, daytime, and nighttime systolic and diastolic 
ambulatory BP and HR in both men and women (all P>0.05). 
 
Table 4. Baseline cardiovascular stress reactivity and the relationship to IHG training 
adaptations on resting BP and HR. 
  
∆ Systolic 
BP 
(mmHg) r P 
∆ Diastolic 
BP 
(mmHg) r P 
∆  HR 
(beats/ 
minute) r P 
Women (n=13) 
         
IHGT 14 ± 3⁺ -0.66 0.01 9 ± 5 -0.28 0.35 8 ± 5 -0.13 0.66 
SST 11 ± 6⁺ -0.28 0.35 8 ± 3 0.01 0.96 8 ± 4 -0.23 0.94 
CPT 20 ± 8 0.05 0.86 13 ± 5 0.1 0.73 10  ± 6 -0.31 0.29 
Men (n=13) 
         IHGT 22 ± 8 -0.66 0.01 11 ± 5 -0.26 0.39 10 ± 5 0.18 0.54 
SST 16 ± 5 0.01 0.97 11 ± 7 0.13 0.67 14 ± 5 0.04 0.90 
CPT 24 ± 10 -0.12 0.70 13 ± 7 -0.47 0.10 10 ± 5 0.39 0.18 
 
BP, blood pressure; HR, heart rate; IHGT, isometric handgrip task; SST, serial subtraction task; 
CPT, cold-pressor task. Values are mean ± SD; One-way ANOVA; ⁺Significantly different from 
men (P<0.05) 
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Figure 4. Correlation analysis of systolic BP reactivity to a(n) (a) isometric handgrip task 
(IHGT) in women (n=13; r=-0.66, P=0.01) and men (n=13; r=-0.66, P=0.01) (b) serial 
subtraction task (SST) in women (n=13; r=-0.03, P=0.35) and in men (n=13; r=0.01, 
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P=0.97), and a (c) cold-pressor task (CPT) in women (n=13; r=0.05, P=0.87 and in men 
(n=13; r=-0.12, P=0.70). 
 
Effect of IHG Training on Cardiovascular Reactivity 
 
Following the 10 week intervention, all measures of cardiovascular reactivity to 
the IHGT, SST, and CPT remained unchanged (all P>0.05).  These data are presented in 
Table 5.  
 
Table 5. Cardiovascular reactivity responses pre- and post-IHG training 
 
 
Women (n=13) Men (n=13) 
Pre Post Pre Post 
Isometric Handgrip Task     
Δ Systolic BP (mmHg) 14 ± 3 13 ± 4 22 ± 8 21 ± 7 
Δ Diastolic BP (mmHg) 8 ± 5 9 ± 5 11 ± 5 13 ± 7 
Δ HR (beats/minute) 
 
8 ± 4 10 ± 4 10 ± 5 10 ± 3 
Serial Subtraction Task     
Δ Systolic BP (mmHg) 11 ± 6  10 ± 5 16 ± 5 15 ± 6 
Δ Diastolic BP (mmHg)  8 ± 3 7 ± 4 11 ± 6 9 ± 5 
Δ HR (beats/minute) 
 
8 ± 4 10 ± 4 14 ± 5 13 ± 7 
Cold-Pressor Task     
Δ Systolic BP (mmHg) 20 ± 8 21 ± 6 24 ± 10 22 ± 9 
Δ Diastolic BP (mmHg) 13 ± 5 13 ± 6 13 ± 7 13 ± 6 
Δ HR (beats/minute) 9 ± 6 9 ± 5 10 ± 7 11 ± 6 
 
BP, blood pressure; HR, heart rate. Values are mean ± SD; RM ANOVA (all P>0.05). 
 
2.6 Discussion 
 
The present study is the first to demonstrate that in young, healthy individuals, 
systolic BP reactivity to an IHGT is significantly associated with reductions in resting 
systolic BP in both men and women following 10 weeks of IHG training. This study also 
represents the first direct comparison of the BP lowering effects of IHG training in young 
normotensive men versus women. Importantly, and accordance with the hypothesis, 
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resting systolic BP reductions occurred equally in both men and women, and were 
concomitant to equal and significant reductions in all measures of systolic ambulatory 
BP, a measure with greater prognostic value than resting BP (Pickering et al., 2006). Also 
noteworthy, all participants in the study demonstrated reductions in resting systolic BP of 
at least 1 mmHg. It has been suggested that a reduction in systolic BP as low as 2 mmHg 
is related to a 10% lower mortality rate from stroke and a 7% lower mortality rate from 
ischemic heart disease (Verdecchia et al., 2012). These novel findings have important 
clinical implications, as they may provide a preventative tool to identify young, healthy 
individuals who will respond to IHG therapy, potentially reducing the future risk of HT 
development. 
 
Effects of IHG Training on BP and HR  
 
 The significant, similar reductions in resting systolic BP observed in both men (4 
mmHg) and women (3 mmHg) also support the initial study hypothesis, and confirm the 
effectiveness of IHG training as a method of lowering resting BP in young, healthy 
individuals (Millar et al., 2014; Howden et al., 2002; McGowan et al., 2007; Wiles et al., 
2010; Badrov et al., 2013b). This work supports previous work from our laboratory 
(Hanik et al., 2012), where BP was found to be equally reduced in young men and 
women following 8 weeks of IHG training. These collective findings in young, men and 
women contrast findings by Millar and colleagues (2009) in older normotensives where 
greater reductions in systolic BP were observed in women than aged-matched men 
following 8 weeks of IHG training. This dissimilar outcome may be due to age 
differences in the study population and/or the duration of the protocol. It is possible that 
an IHG intervention in older normotensives lasting 10 weeks versus 8 weeks could 
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produce similar results in men and women and normalize the differences observed at 8 
weeks. 
A key novel finding of the current work was that pulse pressure was also 
significantly lowered to a similar extent in both men and women. This finding mirrors 
work by Badrov and colleagues (2013a) in hypertensive participants, and as mentioned 
previously, pulse pressure is an accurate predictor of CVD risk (Blacher et al., 2000). 
Thus, the observed reductions in young men and women are clinically important for 
primary prevention of HT efforts (Blacher et al., 2000; Badrov et al., 2013a). 
In contrast to numerous IHG and IL interventions in normotensive and 
hypertensive participants (Wiley et al., 1992; Ray & Carrasco, 2000; Taylor et al., 2003; 
McGowan et al., 2006; Peters et al., 2006; Millar et al., 2008; Wiles et al., 2010; 
Devereux et al., 2010; Baross et al., 2012; Millar et al., 2013; Badrov et al., 2013a; 
Badrov et al., 2013b), no significant reductions in diastolic BP and MAP were observed 
in the current study. This dissimilar finding could be due to population differences in 
baseline BP, as it has been demonstrated that hypertensive participants demonstrate larger 
IHG training-induced reductions in resting BP than do normotensives (Wiley et al., 1992; 
Howden et al., 2002; Taylor et al., 2003; Millar et al., 2007; Baross et al., 2012; Badrov 
et al., 2013b; Millar et al., 2014). It is also possible that with a stimulus greater than 30% 
of MVC, the performance of more repetitions per session, a frequency greater than three 
trainings per week, and/or interventional length greater than 10 weeks, reductions in 
resting diastolic BP and MAP may be observed. 
 With respect to resting HR, no changes were found following the 10 week 
intervention in men and women, which is in line with the majority of IHG training data to 
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date (Wiley et al., 1992; Ray & Carrasco, 2000; Howden et al., 2002; Taylor et al., 2003; 
McGowan et al., 2006; McGowan et al., 2007a; McGowan et al., 2007b; Peters et al., 
2006; Millar et al., 2008; Millar et al., 2013; Wiles et al., 2010; Devereux et al., 2010; 
Stiller-Moldovan et al., 2012; Badrov et al., 2013a; Badrov et al., 2013b). A recent meta-
analysis performed by Carlson and colleagues (2014) revealed a slight statistical 
reduction in resting HR following three IHG training trials in normotensives and 
hypertensives (Badrov et al., 2013b; Taylor et al., 2003; Wiley et al., 1992) and one IL 
training trial in older, hypertensive men (Baross et al., 2013). However, the authors make 
note that the effect size of the analysis was small suggesting that HR is an unlikely factor 
in mediating reductions in BP following IHG training. Because significant reductions in 
resting HR following IHG and IL interventions have largely been found in the 
hypertensive cohort, it is possible reductions were not observed in young, normotensives 
due to baseline BP differences and medication status (Millar et al., 2014). A greater 
stimulus targeting interventional length, frequency of training, and/or force of contraction 
may be required in this population to observe changes in resting HR. 
 The present study provides the first evidence to demonstrate significant systolic 
BP reductions in all measures of ambulatory BP following 10 weeks of IHG training, 
thus supporting the study hypothesis and the exploratory prediction that ambulatory BP 
would be lowered equally in men and women. The reductions in daytime systolic 
ambulatory BP following IHG training were similar in magnitude to reductions following 
aerobic training interventions (3mmHg) in normotensive participants (Cornelissen & 
Smart, 2013; Cornelissen et al., 2011). In contrast, reductions in ambulatory BP 
following dynamic resistance training have not been observed to date (Blumenthal et al. 
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1991; Van Hoof et al., 1996). Of note, the findings of this study are unique from those 
observed with aerobic training in that not only were reductions found in daytime systolic 
ambulatory BP but significant reductions in 24-hour and nighttime systolic BP were also 
observed following the IHG intervention. These observations are in line with previous 
work by Stiller-Moldovan and colleagues (2012), where clinically relevant reductions in 
mean 24-hour and nighttime ambulatory systolic BP were noted following 8 weeks of 
IHG training in well-controlled, medicated hypertensive participants. The implications of 
these findings are tremendous as ambulatory BP is a more reliable predictor of CVD risk 
than traditional resting BP measures (Fagard et al., 2008; Pickering et al., 2006). More 
specifically, nightime ambulatory BP appears to be a stronger predictor of CVD risk than 
daytime ambulatory BP, and thus the finding that systolic nighttime ambulatory BP was 
equally reduced in both men and women is important from a primary prevention 
standpoint (Hansen et al., 2010). These novel findings validate the use of IHG training as 
an effective tool in lowering ambulatory BP in young, healthy individuals. Further, they 
suggest a need for further investigation into the effects of IHG training on ambulatory BP 
in the hypertensive population, who would benefit greatly from the BP lowering effects.  
 Also in line with observations by Stiller-Moldovan and colleagues (2012) in IHG 
training, as well as with dynamic resistance training (Blumenthal et al. 1991; Van Hoof et 
al, 1996), no changes in all measures of ambulatory diastolic BP and ambulatory HR 
were found following the 10 week intervention employed in the current study. Although 
this finding parallels work in the field of isometric and dynamic resistance training, it is 
in contrast to observations following aerobic training interventions where daytime 
diastolic BP reductions of ~-3 mmHg were noted in normotensives, however no changes 
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in ambulatory HR were found (Cornelissen et al., 2013). Again, these dissimilar results 
could mean a greater stimulus targeting intervention length, frequency of training per 
week, and/or contraction force is required to observe reductions in diastolic ambulatory 
BP and HR.  
 
Cardiovascular Reactivity and IHG Training Responsiveness 
 
In support of the current study hypothesis, the present prospective study 
demonstrated that systolic BP reactivity to an IHGT is significantly correlated with the 
IHG training-induced reductions in resting systolic BP in young men and women. The 
inter-individual variability associated with IHG training is well documented in the 
literature, as well as its relationship to cardiovascular stress reactivity responses (Millar et 
al., 2009; Badrov et al., 2010; Badrov et al., 2013a). These findings are in line with the 
existing literature in individuals with HT (Badrov et al., 2013a) and are the first to 
examine sex differences in response to the IHGT. The IHGT aimed to differentiate 
individuals who exhibit high reactivity or large increases in sympathetic activity in 
response to psychophysiological stress (mediated by psychological and physiological 
processes), which with repeated exposure can lead to sustained increases in TPR, 
eventually leading to the development of HT (Flaa et al., 2008; Steptoe, 2008). Thus, the 
IHGT served to mimic a psychophysiological stressor as acute exposure to the task elicits 
a β-adrenergic response causing increases in BP mediated via increases in Q (Badrov et 
al., 2013a).The current work,  suggests that individual differences in reactivity to the 
IHGT, represented by central neuroregulatory mechanisms, play a role in IHG training 
induced reductions in resting BP (Millar et al., 2009). This work provides confirmatory 
evidence that an IHGT can be used effectively to predict the outcome of an IHG 
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intervention. Of particular importance, this work is evidence that the IHGT is effective in 
young, men and women, thus supporting its use in conjunction with IHG training itself as 
a strategy for primary prevention of HT. Specifically, the IHGT would be a viable, 
simple and efficient tool for health care professionals to identify young individuals who 
may be at risk of future HT development and ultimately prescribe IHG training as a 
prevention strategy. 
Another novel finding from the current work is the observation that men have a 
higher systolic BP reactivity to an IHGT and SST than women. In accordance with this, a 
meta-analysis by Stoney and colleagues (1987) show that men exhibit higher systolic BP 
changes than women during acute behavioural stressors. Despite this observed difference 
in systolic BP reactivity to the stressors, the IHGT (induces increases in HR via β‐
adrenergic stimulation) proved to be an equally effective tool for both sexes, such that the 
systolic BP response to the IHGT was predictive of reductions in resting systolic BP 
following the intervention in men and women. Hart and colleagues (2011) have explored 
sex differences in β‐adrenergic stimulation and observed that β‐adrenergic receptors, 
involved in vasodilation, blunt the vasoconstrictor effect of SNS activity in 
premenopausal women, which was a mechanism not observed in age-matched men. This 
study provides insight into the mechanisms behind sex differences in BP regulation and 
may explain why men had a greater systolic BP reactivity than women. 
In contrast to findings by Millar and colleagues (2009) in older normotensives and 
Badrov and colleagues (2013a) in the hypertensive cohort, no significant association was 
found between systolic BP reactivity to a SST and reductions in resting systolic BP 
following the intervention. A possible explanation for this incongruent outcome may be 
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due to the nature of the task. Allen (2000) posits mental arithmetic tasks are differentially 
challenging to participants who vary in mathematical intelligence and academic 
achievement, and can thus influence reactivity to the stressor. Given that the population 
recruited in this study consisted primarily of university students, the stress induced by the 
task may have been blunted due to familiarity with testing scenarios and/or math and 
math-like tasks (Allen, 2000), and thus the SST may not have posed as an adequate 
stressor. Many studies have questioned the ecological validity of the SST, and have 
suggested using other forms of mental or physical stressors for a more accurate testing 
response such as delivering a presentation, a multi-tasking stressor, or a stressful 
interview (Hughes et al., 2014; Sieverding et al., 2005; Waldstein et al., 1998).  
As expected and in support of the mechanisms by which BP is posited to increase 
during presentation of a CPT (elicits α-adrenergic induced increases in TPR), systolic BP 
reactivity to the physical stressor was not predictive of reductions in resting systolic BP 
following the intervention. This outcome is parallel to previous work in stress reactivity 
in both young and old, normotensive and hypertensive participants and confirms that 
increases in BP during the CPT are due to increases in TPR versus Q (Flaa et al., 2008; 
Millar et al., 2009; Badrov et al., 2013a). 
Again, in contrast to the retrospective observations of Millar and colleagues 
(2009) in older normotensives, diastolic BP and HR reactivity to the SST was not 
predictive of IHG training induced reductions in resting systolic BP in the current study. 
This finding is also in contrast to a prospective analysis by Badrov and colleagues 
(2013a) in hypertensive participants where diastolic BP and HR reactivity to a SST was 
predictive of reductions in resting systolic BP following IHG training and in addition, HR 
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reactivity to an IHGT was also predictive of IHG training-induced reductions in resting 
systolic BP. Due to the paucity of prospective studies in cardiovascular stress reactivity 
and IHG training there are no studies to date to compare the current study observations to 
in young, healthy individuals.  
For the first time in the literature in any population, cardiovascular reactivity 
responses were investigated in this study to ascertain their usefulness as potential 
predictive tools with respect to ambulatory BP-lowering following IHG training. In 
contrast to the exploratory hypothesis, the current work showed no correlation between 
BP and HR reactivity to the IHGT, SST, nor CPT and post-IHG training reductions in all 
measures of systolic ambulatory BP in both young, men and women. Although thorough 
effort was made to standardize pre- and post-training activities during the ambulatory 
monitoring period, given that there is inherently high variability in BP over a day and 
night cycle and that the standardization of extraneous, unanticipated factors (e.g., traffic 
jam, inclement weather, receiving a poor test mark) is difficult (Karmarck et al., 2002), 
examining ambulatory BP for more than one 24-hour period is warranted in future 
investigations to provide a more accurate representation of BP.  
Contrary to the hypothesis that systolic BP reactivity to the IHGT and SST would 
be attenuated following the IHG intervention, as observed by Badrov and colleagues 
(2013a) in hypertensive participants, no significant reductions were found. This finding 
suggests that in normotensive participants a greater contraction stimulus (>30% MVC), 
interventional length (>10 weeks) and/or training frequency (>3 times/week) may be 
required in order to see attenuation in cardiovascular reactivity. Conversely, it is possible 
that the observed outcome supports the assumption that cardiovascular reactivity to stress 
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tasks is stable over time in individuals without pathological changes (Sherwood et al., 
1997). The population studied was within normal resting BP range at baseline and did not 
have any substantial pathological changes throughout the intervention period as BP 
lowered but stayed within healthy range. 
Collectively, these findings provide compelling evidence to support the use of 
IHG therapy as a stand-alone BP-lowering treatment or as an adjunct to traditional forms 
of aerobic and dynamic resistance exercise in young, healthy individuals, and is equally 
effective in men and women. Furthermore, these findings provide the first evidence that 
this form of therapy lowers ambulatory BP, while again providing evidence that this 
intervention is equally effective in young men and women (Fagard et al., 2008; Pickering 
et al., 2006). The prognostic significance of these latter observations warrants further 
investigation. Taken together, this work suggests that systolic BP reactivity to a short and 
simple IHGT can be used as a predictive tool for both young normotensive men and 
women. This has tremendous implications for identifying who will respond best to IHG 
training, potentially reducing risk of future HT development. In addition, future work 
should aim to explore how the IHG training stimulus could be optimized in non-
responders (individuals who do not experience reductions in BP following traditional 
IHG training), to ensure that they too, experience reductions in resting BP. 
2.7 Clinical Significance  
 
The positive findings of the present study support the use of IHG training as a 
time efficient means for the young, normotensive population to lower resting systolic BP, 
while offering novel support for its efficacy in lowering systolic ambulatory BP. 
Considering the tremendous prevalence of CVD in Canada and worldwide, and the recent 
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priority placed on primary prevention of HT by the WHO, IHG training represents a 
cornerstone strategy for primary prevention of HT development targeted at the young, 
healthy population. Furthermore, the finding that systolic BP reactivity to an IHGT is 
predictive of IHG responsiveness may be a clinically useful tool in identifying young 
men and women who will benefit most from this form of exercise. 
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Appendices 
Appendix A: Raw Data for Chapter 2 
 
Participant Characteristics 
 
ID Group Age (years) Height 
(cm) 
Weight 
(kg) 
BMI 
(kg/m
2
) 
1 Women 38 155 45 18 
2 Women 23 164 67 25 
3 Women 21 161 63 22 
4 Women 24 170 56 21 
5 Women 24 152 61 20 
6 Women 24 164 65 22 
7 Women 22 175 59 19 
8 Women 23 182 49 21 
9 Women 23 176 72 23 
10 Women 33 171 63 21 
11 Women 23 174 54 20 
12 Women 19 165 79 23 
13 Women 30 164 79 32 
14 Men 25 177 85 27 
15 Men 24 170 65 22 
16 Men 21 185 97 28 
17 Men 22 183 111 33 
18 Men 23 173 70 23 
19 Men 28 190 77 21 
20 Men 24 183 88 26 
21 Men 24 175 68 22 
22 Men 38 176 84 27 
23 Men 20 177 79 25 
24 Men 23 179 58 18 
25 Men 22 179 75 23 
26 Men 24 192 100 27 
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Resting Systolic Blood Pressure Data 
 
ID Group Pre-IHG 
Training SBP 
(mmHg) 
Post-IHG 
Training SBP 
(mmHg) 
1 Women 96 92 
2 Women 104 101 
3 Women 102 99 
4 Women 106 102 
5 Women 101 99 
6 Women 108 103 
7 Women 97 94 
8 Women 102 97 
9 Women 102 101 
10 Women 105 103 
11 Women 94 88 
12 Women 109 103 
13 Women 114 112 
14 Men 116 112 
15 Men 113 111 
16 Men 125 122 
17 Men 112 109 
18 Men 123 120 
19 Men 106 101 
20 Men 113 109 
21 Men 119 114 
22 Men 123 116 
23 Men 117 108 
24 Men 117 114 
25 Men 113 110 
26 Men 119 113 
IHG, isometric handgrip; SBP, systolic blood pressure 
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Resting Diastolic Blood Pressure Data 
 
ID Group Pre-IHG 
Training DBP 
(mmHg) 
Post-IHG 
Training DBP 
(mmHg) 
1 Women 50 50 
2 Women 56 55 
3 Women 60 59 
4 Women 74 71 
5 Women 61 57 
6 Women 59 66 
7 Women 60 58 
8 Women 59 54 
9 Women 60 64 
10 Women 63 66 
11 Women 52 53 
12 Women 75 66 
13 Women 74 78 
14 Men 55 65 
15 Men 67 62 
16 Men 73 78 
17 Men 65 74 
18 Men 82 78 
19 Men 58 59 
20 Men 60 55 
21 Men 64 62 
22 Men 69 71 
23 Men 57 48 
24 Men 62 66 
25 Men 63 68 
26 Men 67 60 
IHG, isometric handgrip; DBP, diastolic blood pressure 
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Resting Heart Rate 
 
ID Group Pre-IHG 
Training HR 
(beats/minute) 
Post-IHG 
Training HR 
(beats/minute) 
1 Women 64 68 
2 Women 64 64 
3 Women 86 85 
4 Women 81 68 
5 Women 58 67 
6 Women 79 58 
7 Women 75 68 
8 Women 56 50 
9 Women 48 45 
10 Women 77 83 
11 Women 60 63 
12 Women 65 59 
13 Women 84 74 
14 Men 57 66 
15 Men 57 57 
16 Men 72 78 
17 Men 77 76 
18 Men 74 76 
19 Men 69 65 
20 Men 50 54 
21 Men 56 68 
22 Men 60 65 
23 Men 59 61 
24 Men 66 58 
25 Men 65 54 
26 Men 60 65 
IHG, isometric handgrip; HR, heart rate 
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Resting Mean Arterial Pressure 
 
ID Group Pre-IHG  
MAP (mmHg) 
Post-IHG 
MAP (mmHg) 
1 Women 65 64 
2 Women 72 70 
3 Women 74 72 
4 Women 85 81 
5 Women 74 71 
6 Women 75 78 
7 Women 72 70 
8 Women 73 68 
9 Women 74 76 
10 Women 77 78 
11 Women 66 65 
12 Women 86 78 
13 Women 87 89 
14 Men 75 81 
15 Men 82 78 
16 Men 90 93 
17 Men 81 86 
18 Men 96 92 
19 Men 74 73 
20 Men 78 73 
21 Men 82 79 
22 Men 87 86 
23 Men 77 68 
24 Men 80 82 
25 Men 80 82 
26 Men 84 78 
IHG, isometric handgrip; MAP, mean arterial pressure 
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Resting Pulse Pressure 
 
ID Group Pre-IHG  
Pulse Pressure 
(mmHg) 
Post-IHG Pulse 
Pressure 
(mmHg) 
1 Women 46 42 
2 Women 48 46 
3 Women 42 40 
4 Women 32 31 
5 Women 40 42 
6 Women 49 37 
7 Women 37 36 
8 Women 43 43 
9 Women 42 37 
10 Women 42 37 
11 Women 42 35 
12 Women 34 37 
13 Women 40 34 
14 Men 61 47 
15 Men 46 49 
16 Men 52 44 
17 Men 47 35 
18 Men 41 42 
19 Men 48 42 
20 Men 53 54 
21 Men 55 52 
22 Men 54 45 
23 Men 60 60 
24 Men 55 48 
25 Men 50 42 
26 Men 52 53 
IHG, isometric handgrip 
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Ambulatory Systolic Blood Pressure Data 
 
ID Group Pre-IHG 
Training 
24 hour 
ASBP 
(mmHg) 
Post-IHG 
Training 
24 hour 
ASBP 
(mmHg) 
Pre-IHG 
Training 
Daytime 
ASBP 
(mmHg) 
Post-IHG 
Training 
Daytime 
ASBP 
(mmHg) 
Pre-IHG 
Training 
Nighttime 
ASBP 
(mmHg) 
Pre-IHG 
Training 
Nighttime 
ASBP 
(mmHg) 
1 Women 119 110 126 117 101 95 
2 Women 122 122 125 122 118 115 
3 Women 117 115 118 115 115 115 
4 Women 116 118 120 123 108 109 
5 Women 125 120 132 128 109 107 
6 Women 119 110 122 113 111 104 
7 Women 121 119 129 122 107 114 
8 Women 120 120 119 120 120 120 
9 Women 113 110 117 114 106 103 
10 Women 119 111 121 113 114 105 
11 Women 127 117 129 118 123 113 
12 Men 124 122 129 125 112 115 
13 Men 125 125 126 125 122 130 
14 Men 128 126 128 124 128 133 
15 Men 138 127 143 136 129 110 
16 Men 138 137 140 137 136 137 
17 Men 122 124 123 127 121 120 
18 Men 125 121 129 127 116 109 
19 Men 138 132 145 141 123 114 
20 Men 144 138 149 140 136 134 
21 Men 119 120 122 122 114 115 
22 Men 129 125 129 125 130 125 
23 Men 139 130 142 141 133 112 
24 Men 136 130 136 128 137 136 
IHG, isometric handgrip; ASBP, ambulatory systolic blood pressure 
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Ambulatory Diastolic Blood Pressure Data 
 
ID Group Pre-IHG 
Training 
24 hour 
ADBP 
(mmHg) 
Post-IHG 
Training 
24 hour 
ADBP 
(mmHg) 
Pre-IHG 
Training 
Daytime 
ADBP 
(mmHg) 
Post-IHG 
Training 
Daytime 
ADBP 
(mmHg) 
Pre-IHG 
Training 
Nighttime 
ADBP 
(mmHg) 
Pre-IHG 
Training 
Nighttime 
ADBP 
(mmHg) 
1 Women 68 56 74 60 54 46 
2 Women 70 69 74 72 62 63 
3 Women 65 65 68 63 59 69 
4 Women 72 75 76 83 63 61 
5 Women 69 69 74 75 58 59 
6 Women 69 63 72 68 62 54 
7 Women 75 72 82 77 63 63 
8 Women 68 68 67 69 70 67 
9 Women 63 66 68 72 56 55 
10 Women 67 65 68 68 65 59 
11 Women 80 69 81 71 77 64 
12 Men 63 66 68 68 53 62 
13 Men 67 74 69 72 63 77 
14 Men 66 73 67 74 66 71 
15 Men 79 75 82 84 74 58 
16 Men 83 82 85 86 79 74 
17 Men 62 66 66 68 56 62 
18 Men 71 70 75 74 65 63 
19 Men 82 79 88 87 70 62 
20 Men 83 81 88 84 73 75 
21 Men 58 58 64 58 49 57 
22 Men 70 66 69 67 72 62 
23 Men 73 71 77 78 67 60 
24 Men 77 76 78 73 75 81 
IHG, isometric handgrip; ADBP, ambulatory diastolic blood pressure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
84 
 
Ambulatory Heart Rate Data 
 
ID Group Pre-IHG 
Training 
24 hour 
AHR 
(beats/ 
minute) 
Post-IHG 
Training 
24 hour 
AHR 
(beats/ 
minute) 
Pre-IHG 
Training 
Daytime 
AHR 
(beats/ 
minute) 
Post-IHG 
Training 
Daytime 
AHR 
(beats/ 
minute) 
Pre-IHG 
Training 
Nighttime 
AHR 
(beats/ 
minute) 
Pre-IHG 
Training 
Nighttime 
AHR 
(beats/ 
minute) 
1 Women 76 71 80 76 65 59 
2 Women 67 67 68 68 67 65 
3 Women 81 86 84 83 75 92 
4 Women 73 78 75 81 69 72 
5 Women 79 68 81 74 77 58 
6 Women 64 67 68 73 56 54 
7 Women 87 83 91 85 80 80 
8 Women 78 73 77 76 80 66 
9 Women 78 81 80 82 75 78 
10 Women 57 52 58 54 56 48 
11 Women 66 68 71 69 56 67 
12 Men 59 65 61 65 56 65 
13 Men 66 73 69 74 62 71 
14 Men 72 75 71 74 76 79 
15 Men 70 61 73 62 62 58 
16 Men 82 79 85 79 74 77 
17 Men 54 60 56 64 50 54 
18 Men 72 74 76 79 65 64 
19 Men 66 59 68 62 63 53 
20 Men 73 76 78 82 66 65 
21 Men 56 58 56 60 49 54 
22 Men 70 68 69 67 71 68 
23 Men 65 62 68 67 60 54 
24 Men 69 67 70 67 68 66 
IHG, isometric handgrip; AHR, ambulatory heart rate 
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Serial Subtraction Task Systolic Blood Pressure Reactivity Data 
 
ID Group Pre-IHG  
SBP Reactivity 
(∆ mmHg) 
Post-IHG SBP 
Reactivity  
(∆ mmHg) 
1 Women 15 14 
2 Women 8 10 
3 Women 7 8 
4 Women 26 21 
5 Women 7 10 
6 Women 13 14 
7 Women 5 3 
8 Women 19 15 
9 Women 11 5 
10 Women 7 9 
11 Women 4 9 
12 Women 13 7 
13 Women 3 3 
14 Men 23 21 
15 Men 10 11 
16 Men 16 22 
17 Men 22 20 
18 Men 17 17 
19 Men 9 10 
20 Men 16 15 
21 Men 24 14 
22 Men 22 20 
23 Men 13 13 
24 Men 15 10 
25 Men 9 12 
26 Men 10 5 
IHG, isometric handgrip; SBP, systolic blood pressure 
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Serial Subtraction Task Diastolic Blood Pressure Reactivity Data 
 
ID Group Pre-IHG  
DBP Reactivity 
 (∆ mmHg) 
Post-IHG DBP 
Reactivity  
(∆ mmHg) 
1 Women 6 8 
2 Women 6 5 
3 Women 8 9 
4 Women 15 11 
5 Women 11 15 
6 Women 12 11 
7 Women 5 7 
8 Women 9 10 
9 Women 8 6 
10 Women 5 2 
11 Women 3 2 
12 Women 6 2 
13 Women 6 3 
14 Men 13 12 
15 Men 8 10 
16 Men 14 15 
17 Men 18 14 
18 Men 10 5 
19 Men 6 6 
20 Men 10 11 
21 Men 28 15 
22 Men 8 5 
23 Men 4 2 
24 Men 1 5 
25 Men 10 5 
26 Men 15 15 
IHG, isometric handgrip; DBP, diastolic blood pressure 
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Serial Subtraction Task Heart Rate Reactivity Data 
 
ID Group Pre-IHG  
HR Reactivity 
(∆ beats/minute) 
Post-IHG  
HR Reactivity  
(∆ beats/minute) 
1 Women 8 10 
2 Women 9 11 
3 Women 10 13 
4 Women 14 15 
5 Women 10 15 
6 Women 11 14 
7 Women 7 12 
8 Women 14 13 
9 Women 6 12 
10 Women 10 8 
11 Women 6 2 
12 Women 1 4 
13 Women 4 8 
14 Men 8 9 
15 Men 15 17 
16 Men 7 4 
17 Men 12 16 
18 Men 18 10 
19 Men 14 16 
20 Men 23 25 
21 Men 19 21 
22 Men 20 15 
23 Men 8 8 
24 Men 20 6 
25 Men 8 6 
26 Men 15 20 
IHG, isometric handgrip; HR, heart rate 
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Isometric Handgrip Task Systolic Blood Pressure Reactivity Data 
 
ID Group Pre-IHG  
SBP Reactivity 
(∆ mmHg) 
Post-IHG SBP 
Reactivity  
(∆ mmHg) 
1 Women 17 16 
2 Women 18 18 
3 Women 11 13 
4 Women 13 12 
5 Women 10 10 
6 Women 19 16 
7 Women 10 9 
8 Women 16 15 
9 Women 10 8 
10 Women 12 12 
11 Women 17 16 
12 Women 14 15 
13 Women 9 8 
14 Men 25 24 
15 Men 16 17 
16 Men 25 23 
17 Men 26 24 
18 Men 10 11 
19 Men 15 14 
20 Men 19 17 
21 Men 30 29 
22 Men 24 25 
23 Men 37 33 
24 Men 16 13 
25 Men 11 14 
26 Men 33 33 
IHG, isometric handgrip; SBP, systolic blood pressure 
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Isometric Handgrip Task Diastolic Blood Pressure Reactivity Data 
 
ID Group Pre-IHG  
DBP Reactivity 
 (∆ mmHg) 
Post-IHG DBP 
Reactivity  
(∆ mmHg) 
1 Women 15 12 
2 Women 11 13 
3 Women 12 11 
4 Women 7 9 
5 Women 4 4 
6 Women 11 9 
7 Women 5 5 
8 Women 8 14 
9 Women 10 1 
10 Women 7 6 
11 Women 17 18 
12 Women 6 4 
13 Women 0 8 
14 Men 10 11 
15 Men 6 4 
16 Men 9 10 
17 Men 11 12 
18 Men 6 4 
19 Men 7 8 
20 Men 12 11 
21 Men 12 14 
22 Men 16 25 
23 Men 16 25 
24 Men 7 15 
25 Men 3 10 
26 Men 23 25 
IHG, isometric handgrip; DBP, diastolic blood pressure 
 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
Isometric Handgrip Task Heart Rate Reactivity Data 
 
ID Group Pre-IHG  
HR Reactivity 
(∆ beats/minute) 
Post-IHG  
HR Reactivity  
(∆ beats/minute) 
1 Women 16 15 
2 Women 12 14 
3 Women 10 11 
4 Women 11 13 
5 Women 10 9 
6 Women 14 11 
7 Women 2 5 
8 Women 10 8 
9 Women 3 4 
10 Women 5 15 
11 Women 1 4 
12 Women 2 10 
13 Women 3 10 
14 Men 10 11 
15 Men 9 11 
16 Men 12 9 
17 Men 13 9 
18 Men 12 5 
19 Men 15 14 
20 Men 6 10 
21 Men 18 15 
22 Men 7 6 
23 Men 2 11 
24 Men 8 12 
25 Men 3 10 
26 Men 16 10 
IHG, isometric handgrip; HR, heart rate 
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Cold-Pressor Task Systolic Blood Pressure Reactivity Data 
 
ID Group Pre-IHG  
SBP Reactivity 
(∆ mmHg) 
Post-IHG SBP 
Reactivity  
(∆ mmHg) 
1 Women 30 27 
2 Women 27 28 
3 Women 25 20 
4 Women 23 24 
5 Women 14 15 
6 Women 33 30 
7 Women 8 10 
8 Women 12 18 
9 Women 19 20 
10 Women 20 11 
11 Women 21 30 
12 Women 6 15 
13 Women 24 24 
14 Men 34 33 
15 Men 15 16 
16 Men 24 20 
17 Men 25 22 
18 Men 30 18 
19 Men 11 15 
20 Men 8 10 
21 Men 25 24 
22 Men 35 30 
23 Men 35 30 
24 Men 30 6 
25 Men 35 40 
26 Men 11 24 
IHG, isometric handgrip; SBP, systolic blood pressure 
 
 
 
 
 
 
 
 
 
 
 
 
 
92 
 
Cold-Pressor Task Diastolic Blood Pressure Reactivity Data 
 
ID Group Pre-IHG  
DBP Reactivity 
 (∆ mmHg) 
Post-IHG DBP 
Reactivity  
(∆ mmHg) 
1 Women 23 20 
2 Women 13 14 
3 Women 11 10 
4 Women 9 8 
5 Women 10 11 
6 Women 13 14 
7 Women 5 3 
8 Women 11 18 
9 Women 15 14 
10 Women 18 18 
11 Women 18 22 
12 Women 8 5 
13 Women 15 14 
14 Men 10 11 
15 Men 8 8 
16 Men 11 9 
17 Men 16 14 
18 Men 16 12 
19 Men 13 14 
20 Men 0 5 
21 Men 12 16 
22 Men 25 25 
23 Men 20 10 
24 Men 5 7 
25 Men 20 20 
26 Men 15 18 
IHG, isometric handgrip; DBP, diastolic blood pressure 
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Cold-Pressor Task Heart Rate Reactivity Data 
 
ID Group Pre-IHG  
HR Reactivity 
(∆ beats/minute) 
Post-IHG  
HR Reactivity  
(∆ beats/minute) 
1 Women 14 12 
2 Women 11 15 
3 Women 8 12 
4 Women 7 6 
5 Women 15 13 
6 Women 18 16 
7 Women 5 9 
8 Women 11 13 
9 Women 1 4 
10 Women 18 9 
11 Women 7 2 
12 Women 9 4 
13 Women 0 3 
14 Men 19 17 
15 Men 10 13 
16 Men 17 18 
17 Men 15 14 
18 Men 18 14 
19 Men 14 13 
20 Men 4 10 
21 Men 18 17 
22 Men 6 5 
23 Men 3 7 
24 Men 2 3 
25 Men 6 15 
26 Men 4 0 
IHG, isometric handgrip; HR, heart rate 
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Appendix B: Statistical Analysis for Chapter 2 
 
Participant Baseline Characteristics 
 
One-Way ANOVA: Baseline Age Between-Group Differences 
 
1a. Age (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 24.43 4.35 13 
Women 25.42 5.45 13 
 
1b. Age (All Effects) 
 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Age Between Groups 6.309 1 6.309 .265 .612 
Within Groups 572.345 24 23.848   
Total 578.654 25    
 
One-Way ANOVA: Baseline Height Between-Group Differences 
 
2a. Height (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 178.59 8.54 13 
Women 167.03 9.25 13 
 
2b. Height (All Effects) 
 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Height Between Groups 864.653 1 864.653 10.994 .003 
Within Groups 1887.552 24 78.648   
Total 2752.205 25    
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One-Way ANOVA: Baseline Weight Between-Group Differences 
 
3a. Weight (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 79.80 14.43 13 
Women 63.26 10.82 13 
 
3b. Weight (All Effects) 
 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Weight Between Groups 1767.872 1 1767.872 10.625 .003 
Within Groups 3993.428 24 166.393   
Total 5761.300 25    
 
One-Way ANOVA: Baseline Body Mass Index Between-Group Differences 
 
4a. BMI (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 24.66 3.70 13 
Women 22.65 3.57 13 
 
4b. BMI (All Effects) 
 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
BMI Between Groups 26.183 1 26.183 1.975 .173 
Within Groups 318.204 24 13.259   
Total 344.387 25    
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One-Way ANOVA: Baseline Resting BP and HR Between-Group Differences 
 
5a. Resting SBP (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 117.34 5.44 13 
Women 103.25 5.67 13 
 
5b. Resting SBP (All Effects) 
ANOVA 
SBP   
 Sum of Squares df Mean Square F Sig. 
Between Groups 1191.385 1 1191.385 40.500 .000 
Within Groups 706.000 24 29.417   
Total 1897.385 25    
 
 
 
6a. Resting DBP (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 64.98 7.21 13 
Women 62.24 8.02 13 
 
6b. Resting DBP (All Effects) 
 
ANOVA 
DBP   
 Sum of Squares df Mean Square F Sig. 
Between Groups 58.500 1 58.500 1.005 .326 
Within Groups 1396.615 24 58.192   
Total 1455.115 25    
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7a. Resting HR (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 62.88 8.40 13 
Women 69.43 12.02 13 
 
7b. Resting HR (All Effects) 
ANOVA 
HR   
 Sum of Squares df Mean Square F Sig. 
Between Groups 216.346 1 216.346 2.072 .163 
Within Groups 2506.308 24 104.429   
Total 2722.654 25    
 
 
 
8a. Resting Mean Arterial BP (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 74.10 7.2 13 
Women 75.3 7.4 13 
 
8b. Resting Mean Arterial BP (All Effects) 
 
ANOVA 
MAP   
 Sum of Squares df Mean Square F Sig. 
Between Groups 275.709 1 275.709 6.492 .018 
Within Groups 1019.197 24 42.467   
Total 1294.906 25    
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9a. Resting Pulse Pressure (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 51.85 5.33 13 
Women 41.30 4.7 13 
 
9b. Resting Pulse Pressure (All Effects) 
 
ANOVA 
PP   
 Sum of Squares df Mean Square F Sig. 
Between Groups 721.885 1 721.885 26.153 .000 
Within Groups 662.462 24 27.603   
Total 1384.346 25    
 
One-Way ANOVA: Baseline Ambulatory BP and HR Between-Group Differences 
 
10a. 24 hour Systolic ABP (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 131.45 5.42 13 
Women 120.34 4.03 13 
 
10b. 24 hour Systolic ABP (All Effects) 
 
ANOVA 
SABP   
 Sum of Squares df Mean Square F Sig. 
Between Groups 765.630 1 765.630 18.322 .000 
Within Groups 919.329 22 41.788   
Total 1684.958 23    
 
 
11a. Daytime Systolic ABP (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 133.92 8.64 13 
Women 123.45 4.81 13 
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11b. Daytime Systolic ABP (All Effects) 
 
ANOVA 
DSABP   
 Sum of Squares df Mean Square F Sig. 
Between Groups 652.975 1 652.975 11.721 .002 
Within Groups 1225.650 22 55.711   
Total 1878.625 23    
 
 
12a. Nighttime Systolic ABP (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 125.92 8.27 13 
Women 112.00 6.34 11 
 
12b. Nighttime Systolic ABP (All Effects) 
 
ANOVA 
NSABP   
 Sum of Squares df Mean Square F Sig. 
Between Groups 1155.035 1 1155.035 19.093 .000 
Within Groups 1330.923 22 60.497   
Total 2485.958 23    
 
13a. 24 hour Diastolic ABP (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 72.2 8.09 13 
Women 70.31 5.02 11 
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13b. 24 hour Diastolic ABP (All Effects) 
 
 
ANOVA 
DABP   
 Sum of Squares df Mean Square F Sig. 
Between Groups 29.096 1 29.096 .593 .450 
Within Groups 1080.238 22 49.102   
Total 1109.333 23    
 
14a. 24 hour Ambulatory HR (Means) 
 
Sex Mean Standard 
Deviation 
n 
Men 67.12 7.35 13 
Women 73.2 9.01 11 
 
 
14b. 24 hour Ambulatory HR (All Effects) 
 
 
ANOVA 
AHR   
 Sum of Squares df Mean Square F Sig. 
Between Groups 217.510 1 217.510 3.259 .085 
Within Groups 1468.490 22 66.750   
Total 1686.000 23    
 
 
Effects of IHG Training on Resting and Ambulatory BP and HR 
 
Resting BP and HR Pre- to Post-IHG training Repeated Measures ANOVA 
 
1a. Resting Systolic BP (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 116.62 5.09 13 
Men Post-Training 112.23 5.18 13 
Women Pre-Training 103.07 5.32 13 
Women Post-Training 99.54 5.77 13 
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1b. Resting Systolic BP (All Effects) 
 
 
Tests of Within-Subjects Contrasts 
Measure:   Systolic BP   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 204.019 1 204.019 125.057 .000 
Time * Sex Linear 2.327 1 2.327 1.426 .244 
Error(Time) Linear 39.154 24 1.631   
 
 
2a. Resting Diastolic BP (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 64.77 6.95 13 
Men Post-Training 65.08 8.47 13 
Women Pre-Training 61.77 7.69 13 
Women Post-Training 61.31 7.70 13 
 
2b. Resting Diastolic BP (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Diastolic BP   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear .077 1 .077 .005 .942 
Time * Sex Linear 1.923 1 1.923 .137 .715 
Error(Time) Linear 338.000 24 14.083   
 
3a. Resting MAP (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 82.05 5.88 13 
Men Post-Training 80.79 6.93 13 
Women Pre-Training 75.54 6.62 13 
Women Post-Training 74.05 6.86 13 
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3b. Resting MAP (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Mean Arterial Pressure   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 24.464 1 24.464 3.341 .080 
Time * Sex Linear .173 1 .173 .024 .879 
Error(Time) Linear 175.752 24 7.323   
 
4a. Resting Pulse Pressure (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 51.85 5.33 13 
Men Post-Training 47.15 6.30 13 
Women Pre-Training 41.31 4.75 13 
Women Post-Training 38.23 3.98 13 
 
4b. Resting Pulse Pressure (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Pulse Pressure   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 196.173 1 196.173 16.705 .000 
Time * Sex Linear 8.481 1 8.481 .722 .404 
Error(Time) Linear 281.846 24 11.744   
 
5a. Resting HR (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 63.23 7.70 13 
Men Post-Training 64.85 7.80 13 
Women Pre-Training 69.00 11.56 13 
Women Post-Training 65.54 10.91 13 
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5b. Resting HR (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Heart Rate   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 11.077 1 11.077 .400 .533 
Time * Sex Linear 83.769 1 83.769 3.023 .095 
Error(Time) Linear 665.154 24 27.715   
 
 
 
Ambulatory BP and HR Pre- to Post-IHG training Repeated Measures ANOVA 
5a. 24 hour Systolic Ambulatory BP (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 131.15 7.66 13 
Men Post-Training 127.46 5.47 13 
Women Pre-Training 119.82 3.76 11 
Women Post-Training 115.64 4.42 11 
 
5b. 24 hour Systolic Ambulatory BP (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Ambulatory Systolic BP   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 184.714 1 184.714 22.677 .000 
Time * Sex Linear .714 1 .714 .088 .770 
Error(Time) Linear 179.203 22 8.146   
 
6a. Daytime Systolic Ambulatory BP (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 133.92 8.64 13 
Men Post-Training 130.62 6.90 13 
Women Pre-Training 123.45 4.81 11 
Women Post-Training 118.64 4.60 11 
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6b. Daytime Systolic Ambulatory BP (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Daytime Systolic BP   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 196.714 1 196.714 25.427 .000 
Time * Sex Linear 6.797 1 6.797 .879 .359 
Error(Time) Linear 170.203 22 7.736   
 
6a. Nighttime Systolic Ambulatory BP (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 125.92 8.27 13 
Men Post-Training 122.31 10.14 13 
Women Pre-Training 112.00 6.34 11 
Women Post-Training 109.09 6.82 11 
 
6b. Nighttime Systolic Ambulatory BP (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Nighttime Systolic BP   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 126.819 1 126.819 4.903 .037 
Time * Sex Linear 1.486 1 1.486 .057 .813 
Error(Time) Linear 568.993 22 25.863   
 
7a. 24 hour Diastolic Ambulatory BP (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 71.85 8.13 13 
Men Post-Training 72.08 6.62 13 
Women Pre-Training 69.64 4.48 11 
Women Post-Training 67.00 4.75 11 
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7b. 24 hour Diastolic Ambulatory BP (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Ambulatory Diastolic BP   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 17.240 1 17.240 1.761 .198 
Time * Sex Linear 24.490 1 24.490 2.501 .128 
Error(Time) Linear 215.427 22 9.792   
 
8a. Daytime Diastolic Ambulatory BP (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 75.08 8.26 13 
Men Post-Training 74.85 8.33 13 
Women Pre-Training 73.09 4.94 11 
Women Post-Training 70.73 6.06 11 
 
8b. Daytime Diastolic Ambulatory BP (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Daytime Diastolic BP   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 20.053 1 20.053 1.681 .208 
Time * Sex Linear 13.553 1 13.553 1.136 .298 
Error(Time) Linear 262.427 22 11.928   
 
9a. Nighttime Diastolic Ambulatory BP (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 66.31 8.69 13 
Men Post-Training 66.46 7.68 13 
Women Pre-Training 62.64 6.18 11 
Women Post-Training 60.00 6.31 11 
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9b. Nighttime Diastolic Ambulatory BP (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Nighttime Diastolic BP   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 18.360 1 18.360 .616 .441 
Time * Sex Linear 23.194 1 23.194 .778 .387 
Error(Time) Linear 656.119 22 29.824   
 
10a. 24 hour Ambulatory HR (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 67.23 7.30 13 
Men Post-Training 67.46 6.97 13 
Women Pre-Training 73.27 8.40 11 
Women Post-Training 72.18 9.13 11 
 
10b. 24 hour Ambulatory HR (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Ambulatory HR   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 2.204 1 2.204 .169 .685 
Time * Sex Linear 5.204 1 5.204 .399 .534 
Error(Time) Linear 286.608 22 13.028   
 
11a. Daytime Ambulatory HR (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 69.23 7.90 13 
Men Post-Training 69.38 7.07 13 
Women Pre-Training 75.73 8.66 11 
Women Post-Training 74.64 8.42 11 
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11b. Daytime Ambulatory HR (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Daytime Ambulatory HR   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 2.616 1 2.616 .215 .648 
Time * Sex Linear 4.616 1 4.616 .378 .545 
Error(Time) Linear 268.301 22 12.195   
 
12a. Nighttime Ambulatory HR (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 63.23 63.69 13 
Men Post-Training 7.92 8.42 13 
Women Pre-Training 68.73 9.07 11 
Women Post-Training 67.18 12.13 11 
 
12b. Nighttime Ambulatory HR (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   Nighttime Ambulatory HR   
Source Time Type III Sum of 
Squares 
df Mean Square F Sig. 
Time Linear 3.500 1 3.500 .106 .748 
Time * Sex Linear 12.000 1 12.000 .364 .553 
Error(Time) Linear 725.979 22 32.999   
 
Cardiovascular Reactivity as a Predictor of IHG Training Effectiveness in Men and 
Women  
 
1a. Correlation Analysis (Women)  
 
Marked correlations are significant at p < 0.05 
N=13 
 SSTSBP SSTDBP SSTHR IHGSBP IHGDBP IHGHR CPTSBP CPTDBP CPTHR 
RSBP -0.28 0.01 -0.23 -0.66 -0.28 -0.13 0.05 0.10 -0.31 
 p=0.35 p=0.96 p=0.94 p=0.01 p=0.35 p=0.67 p=0.87 p=0.74 p=0.23 
RSBP, Resting systolic blood pressure 
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Marked correlations are significant at p < 0.05 
N=13 
 SSTSB
P 
SSTDB
P 
SSTH
R 
IHGSB
P 
IHGDB
P 
IHGH
R 
CPTSB
P 
CPTDB
P 
CPTH
R 
ASB
P 
0.23 -0.03 -0.23 -0.33 0.14 0.22 -0.48 -0.17 0.32 
 p=0.72 p=0.48 p=0.56 p=0.61 p=0.49 p=0.63 p=0.82 p=0.89 p=0.97 
ASBP, Ambulatory systolic blood pressure 
 
Marked correlations are significant at p < 0.05 
N=13 
 SSTSB
P 
SSTDB
P 
SSTH
R 
IHGSB
P 
IHGDB
P 
IHGH
R 
CPTSB
P 
CPTDB
P 
CPTH
R 
DASB
P 
0.24 -0.15 -0.29 0.21 0.22 -0.02 0.05 0.34 0.26 
 p=0.74 p=0.68 p=0.93 p=0.74 p=0.49 p=0.58 p=0.55 p=0.86 p=0.14 
DASBP, Daytime ambulatory systolic blood pressure 
 
Marked correlations are significant at p < 0.05 
N=13 
 SSTSB
P 
SSTDB
P 
SSTH
R 
IHGSB
P 
IHGDB
P 
IHGH
R 
CPTSB
P 
CPTDB
P 
CPTH
R 
NASB
P 
0.06 0.14 -0.03 -0.13 0.32 -0.22 0.18 -0.11 -0.23 
 p=49 p=0.75 p=0.44 p=0.45 p=0.58 p=0.24 p=0.51 p=0.81 p=0.54 
NASBP, Nighttime ambulatory systolic blood pressure 
 
1a. Correlation Analysis (Men)  
 
Marked correlations are significant at p < 0.05 
N=13 
 SSTSBP SSTDB
P 
SSTH
R 
IHGSB
P 
IHGDB
P 
IHGH
R 
CPTSB
P 
CPTDB
P 
CPTH
R 
RSB
P 
0.01 0.13 0.04 -0.66 -0.26 0.18 -0.12 -0.47 0.39 
 p=0.97 p=0.67 p=0.92 p=0.01 p=0.40 p=0.54 p=0.70 p=0.10 p=0.19 
RSBP, Resting systolic blood pressure 
 
Marked correlations are significant at p < 0.05 
N=11 
 SSTSB
P 
SSTDB
P 
SSTH
R 
IHGSB
P 
IHGDB
P 
IHGH
R 
CPTSB
P 
CPTDB
P 
CPTH
R 
ASB
P 
0.17 0.07 0.14 0.03 -0.13 0.09 -0.34 0.24 0.15 
 p=0.90 p=0.86 p=0.92 p=0.67 p=0.17 p=0.75 p=0.56 p=0.46 p=0.63 
ASBP, Ambulatory systolic blood pressure 
 
Marked correlations are significant at p < 0.05 
N=11 
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 SSTSB
P 
SSTDB
P 
SSTH
R 
IHGSB
P 
IHGDB
P 
IHGH
R 
CPTSB
P 
CPTDB
P 
CPTH
R 
DASB
P 
-0.23 0.18 -0.25 -0.33 0.18 -0.04 -0.28 0.34 0.22 
 p=0.45 p=0.83 p=0.97 p=0.78 p=0.76 p=0.52 p=0.87 p=0.90 p=0.81 
DASBP, Daytime ambulatory systolic blood pressure 
 
 
 
Marked correlations are significant at p < 0.05 
N=11 
 SSTSB
P 
SSTDB
P 
SSTH
R 
IHGSB
P 
IHGDB
P 
IHGH
R 
CPTSB
P 
CPTDB
P 
CPTH
R 
NASB
P 
-0.26 -0.29 0.12 -0.11 -0.02 0.15 -0.30 -0.09 -0.36 
 p=0.42 p=0.56 p=0.77 p=0.49 p=0.37 p=0.91 p=0.88 p=0.47 p=0.29 
NASBP, Nighttime ambulatory systolic blood pressure 
 
Cardiovascular Reactivity post-IHG Training  
 
SST Systolic BP, Diastolic BP, and HR Reactivity Pre- to Post-IHG training Repeated 
Measures ANOVA 
 
1a. SST Systolic BP Reactivity (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 15.85 5.52 13 
Men Post-Training 14.62 5.14 13 
Women Pre-Training 10.62 6.56 13 
Women Post-Training 9.85 5.12 13 
 
 
1b. SST Systolic BP Reactivity (All Effects)  
 
Tests of Within-Subjects Contrasts 
Source factor1 
Type III Sum of 
Squares df Mean Square F Sig. 
factor1 Linear 13.000 1 13.000 1.811 .191 
factor1 * Sex Linear .692 1 .692 .096 .759 
Error(factor1) Linear 172.308 24 7.179   
 
2a. SST Diastolic BP Reactivity (Means) 
 
Sex Time Mean Standard n 
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Deviation 
Men Pre-Training 11.15 6.84 13 
Men Post-Training 10.23 4.73 13 
Women Pre-Training 7.69 3.32 13 
Women Post-Training 7.00 4.14 13 
 
 
 
 
 
2b. SST Diastolic BP Reactivity (All Effects)  
 
Tests of Within-Subjects Contrasts 
Source TIME 
Type III Sum of 
Squares df Mean Square F Sig. 
TIME Linear 22.231 1 22.231 3.561 .071 
TIME * Sex Linear 4.923 1 4.923 .789 .383 
Error(TIME) Linear 149.846 24 6.244   
 
3a. SST HR Reactivity (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 14.38 5.44 13 
Men Post-Training 13.31 6.60 13 
Women Pre-Training 8.46 3.71 13 
Women Post-Training 10.54 4.05 13 
 
3b. SST HR Reactivity (All Effects)  
Tests of Within-Subjects Contrasts 
 
Source TIME 
Type III Sum of 
Squares df Mean Square F Sig. 
TIME Linear 3.250 1 3.250 .351 .559 
TIME * Sex Linear 32.327 1 32.327 3.496 .074 
Error(TIME) Linear 221.923 24 9.247   
 
IHGT Systolic BP, Diastolic BP, and HR Reactivity Pre- to Post-IHG training Repeated 
Measures ANOVA 
 
4a. IHGT Systolic BP Reactivity (Means) 
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Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 22.08 8.38 13 
Men Post-Training 21.31 7.55 13 
Women Pre-Training 13.54 3.50 13 
Women Post-Training 12.92 3.38 13 
 
 
 
 
4b. IHGT Systolic BP Reactivity (All Effects) 
 
Tests of Within-Subjects Contrasts 
 
Source TIME 
Type III Sum of 
Squares df Mean Square F Sig. 
TIME Linear 6.231 1 6.231 4.718 .060 
TIME * Sex Linear .077 1 .077 .058 .811 
Error(TIME) Linear 31.692 24 1.321   
 
5a. IHGT Diastolic BP Reactivity (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 10.62 5.36 13 
Men Post-Training 13.38 7.35 13 
Women Pre-Training 8.69 4.63 13 
Women Post-Training 8.77 4.78 13 
 
5b. IHGT Diastolic BP Reactivity (All Effects) 
 
Tests of Within-Subjects Contrasts 
 
Source TIME 
Type III Sum of 
Squares df Mean Square F Sig. 
TIME Linear 26.327 1 26.327 3.118 .090 
TIME * Sex Linear 23.558 1 23.558 2.790 .108 
Error(TIME) Linear 202.615 24 8.442   
 
6a. IHGT HR Reactivity (Means) 
 
Sex Time Mean Standard n 
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Deviation 
Men Pre-Training 10.08 4.87 13 
Men Post-Training 10.23 2.74 13 
Women Pre-Training 7.62 5.12 13 
Women Post-Training 9.92 3.86 13 
 
 
 
 
 
6b. IHGT HR Reactivity (All Effects) 
 
Tests of Within-Subjects Contrasts 
   
Source TIME 
Type III Sum of 
Squares df Mean Square F Sig. 
TIME Linear 19.692 1 19.692 1.992 .171 
TIME * Sex Linear 15.077 1 15.077 1.525 .229 
Error(TIME) Linear 237.231 24 9.885   
 
 
CPT Systolic BP, Diastolic BP, and HR Reactivity Pre- to Post-IHG training Repeated 
Measures ANOVA 
 
7a. CPT Systolic BP Reactivity (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 24.46 10.04 13 
Men Post-Training 22.15 9.51 13 
Women Pre-Training 20.15 8.21 13 
Women Post-Training 20.92 6.89 13 
 
7b. CPT Systolic BP Reactivity (All Effects) 
 
Tests of Within-Subjects Contrasts 
 
Source TIME 
Type III Sum of 
Squares df Mean Square F Sig. 
TIME Linear 7.692 1 7.692 .292 .594 
TIME * Sex Linear 30.769 1 30.769 1.167 .291 
Error(TIME) Linear 632.538 24 26.356   
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8a. CPT Diastolic BP Reactivity (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 13.15 6.68 13 
Men Post-Training 13.00 5.66 13 
Women Pre-Training 13.00 4.83 13 
Women Post-Training 13.15 5.67 13 
 
8b. CPT Diastolic BP Reactivity (All Effects) 
 
Tests of Within-Subjects Contrasts 
 
Source TIME 
Type III Sum of 
Squares df Mean Square F Sig. 
TIME Linear .000 1 .000 .000 1.000 
TIME * Sex Linear .308 1 .308 .054 .818 
Error(TIME) Linear 136.692 24 5.696   
 
 
9a. CPT HR Reactivity (Means) 
 
Sex Time Mean Standard 
Deviation 
n 
Men Pre-Training 10.46 6.54 13 
Men Post-Training 11.23 5.78 13 
Women Pre-Training 9.54 5.75 13 
Women Post-Training 9.08 4.82 13 
 
 
9b. CPT HR Reactivity (All Effects) 
 
Tests of Within-Subjects Contrasts 
Measure:   MEASURE_1   
Source TIME 
Type III Sum of 
Squares df Mean Square F Sig. 
TIME Linear .308 1 .308 .038 .847 
TIME * Sex Linear 4.923 1 4.923 .610 .443 
Error(TIME) Linear 193.769 24 8.074   
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Appendix C: Recruitment Materials for Young, Healthy Population 
 
 
Investigators at the University of Windsor are currently looking for 
individuals between age 18-40 years with normal blood pressure to 
participate in a study examining the effects of isometric handgrip exercise on 
blood pressure, heart rate and blood vessels. 
 
If you are interested and would like more information please 
contact Sarah Hanik, BSc or YasinaSomani, BSc: (519)-253-3000 
ext. 4979 or hanik@uwindsor.ca, somaniy@uwindsor.ca 
 
This study has been cleared by the University of Windsor’s Research Ethics Board 
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Local media/newspaper/email recruitment script: 
"Attention all men and women between age 18-40 years with normal blood pressure. You 
may be eligible to participate in a research study being conducted by investigators at the 
University of Windsor. We are investigating the effects of ten weeks of isometric 
handgrip exercise training on your blood pressure, heart rate and blood vessels. For more 
information please contact Sarah Hanik or YasinaSomani at 519-253-3000 ex. 4979 or 
hanik@uwindosr.ca, somaniy@uwindsor.ca." 
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Appendix D: Consent to Participate in Research Form 
 
  
CONSENT TO PARTICIPATE IN RESEARCH 
 
Title of Study: Isometric Exercise Training and Blood Pressure 
Regulation: Exploring Sex- and Age-Related Differences 
 
You are asked to participate in a 10-week isometric exercise training 
research study conducted jointly between the University of Windsor and The 
University of Northampton (Northampton, England). Your total time 
commitment for the entire study is ~ 22 hours: a) determining if you qualify 
to participate in the study (~I hour), b) testing days (~6 hours total), and c) 
exercise training (~30 minutes, 3X per week; ~15 hours total). 
 
If you have any questions or concerns about the research at the University of 
Windsor site, please feel to contact Cheri McGowan, PhD (519-253-3000 
ext. 2451; mcgowanc@uwindsor.ca), or Kevin Milne, PhD (519-253-3000 
ext. 2452; kjmilne@windsor.ca). For questions or concerns during non-
working hours, please contact Cheri McGowan, PhD via cell phone at 734-
904- 8488. 
 
PURPOSE OF THE STUDY 
 
Our research groups in Canada and England have shown that isometric 
(constant squeeze) exercise training using a handgrip (isometric handgrip 
(IHG) training) and leg machine (isometric leg training) lowers resting blood 
pressure inyounger and older people who have high blood pressure, and 
even in those with normal blood pressure. However, we do not know why it 
works. Not all people have a drop in their blood pressure after training, so 
identifying those people it will help is also important.  
 
The part of the study at the University of Windsor site,willsee if certain tasks 
(e.g., a handgrip squeeze or a simple math test) that raise your heart rate and 
blood pressure can predict who will have a drop in their resting blood 
pressure after 10 weeks handgrip training, 3 times a week. In addition, we 
will test the function of some of your blood vessels, as well as the             
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activity of your nervous system. Our study will also see whether men and 
women respond differently, and if younger and older people respond 
differently.  
 
In order to participate in this study you must have a normal blood pressure 
(<140/90 mmHg). You must be 18-40 years or 60-80 years of age to 
participate in this study. If you have a disorder or any known ailments or are 
taking any medications that influence your cardiovascular system you may 
be ineligible to participate. If you have a physical limitation impairing your 
ability to exercise you may also be ineligible to participate.  
 
PROCEDURES 
 
If you volunteer to participate in this study, you will be asked to attend the 
following: 
 
Visit 1 (approximately 30 minutes): 
 
You will meet with the study investigators at the Physical Activity and 
Cardiovascular Research (PACR) Laboratory (Room #240, Human Kinetics 
Building, University of Windsor, Windsor, Ontario, Canada) where you will 
receive a consent form and information sheet about the study. At this time, 
one of the study investigators will explain all parts of the study. If you are 
still interested in participating in the study, you will be asked to sign the 
consent form and fill out a brief medical questionnaire.You will then have 
your blood pressure measured in your upper arm, similar to how it is taken at 
a doctor’s officeIn brief, your resting blood pressure will be measured in 
your upperdominant arm after 10 minutes of seated rest. Your blood 
pressure will be measured 4 times, with 2-minutes of rest between measures. 
 
Visit 2 (approximately 30 minutes): 
 
If you are still interested in participating in the study, and you are initially 
eligible after Visit 1, you will visit the lab again.  First, you will have your 
resting blood pressure measured again, in the same manner as the first visit. 
If your blood pressure is still <140/90 mmHg, you will then practice all parts 
of the study including the math task and the handgrip exercise. After you 
practice all parts of the study, you will be asked to complete a physical 
activity readiness questionnaire called a PAR-Q, and if needed, a more 
detailed form called the PAR-MedX. You will also receive two letters to be 
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taken to your health care provider. One will notify your health care provider 
of your involvement in the study and the second is to be signed by your 
health care provider and returned to us. Upon receiving this document you 
will then choose the dates to complete the 3 days of testing. All testing days 
will be separated by at least 24 hours. 
 
Testing Days (Visits 3-4): 
 
You will be asked not to exercise vigorously (e.g., exercise that causes you 
to breath really hard and sweat heavily) or drink alcohol for 24 hours before 
each testing day, and to avoid caffeine for at least 12 hours before. All 
testing will take place at the same time of day, in a quiet, temperature-
controlled room, following a light meal for visit 3 and 4 hours after eating 
for visit 4. On testing days, you will be asked to go to the washroom before 
testing, as a full bladder can increase your blood pressure. 
 
All 3 testing days will happen again after 10 weeks of handgrip training 
(Week 11). You will train 3 times per week, for a total of 10 weeks. You 
will perform 4, 2-minute squeezes at 30% of your maximum squeeze, using 
both hands (each separated by 1 minute of rest) on a computerized handgrip. 
All training sessions will be supervised by an exercise trainer, where your 
resting blood pressure and heart rate will be measured before each session. 
Training sessions should not last longer than 30 minutes. Your exercise, 
nutritional, and medication habits (where necessary) will be monitored in 
exercise log books throughout the study to make sure they do not change. 
 
Visit 3 (approximately 3 hours): 
 
Upon entering the lab, your resting blood pressure and heart rate will be 
measured in the same way that it was measured in the previous visits. After 
that, your blood pressure and heart rate will be measured continuously for 10 
minutes. Continuous blood pressure will be measured by a small cuff placed 
around your middle finger on your dominant hand, and continuous heart rate 
will be measured by using 3 sticker electrodes that will be placed on your 
chest. 
 
After that, we will remove the finger blood pressure cuff, but the cuff on 
your upper arm and the sticker electrodes on your chest will stay in place. 
You will then perform 3 tasks in random order (i.e., chosen by chance). 
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These include: 1) a short handgrip exercise, 2) a task where you place your 
hand in cold water, and 3) a math task.  
 
The short handgrip task will involve you performing a single 2-minute 
squeeze at 30% of your maximum squeeze on a computerized handgrip 
using your non-dominant hand. The math task will involve looking at a 
computer and subtracting a 2-digit number from a 4-digit number displayed 
and responding with your answer aloud. You will be shown 25 numbers in 
total and will have 5 seconds answer each one.  Finally, the cold water task 
will involve you placing your right hand in cold water (~4°C) for 2-
minutes.Heart rate and blood pressure (every  
minute) will be measured during and after each task, and once both heart 
rate and blood pressure have stabilized, you will begin the next task. 
 
At the end of the testing session, we will send you home with a machine that 
will record your blood pressure for the next 24-hours. The morning 
following, you will return this device to us. 
 
Visit 4 (approximately 3 hours): 
 
First, your resting blood pressure and heart rate will be measured in the same 
way as it was on your other visits.  
 
Next, we will take a picture of an artery in your heart using an ultrasound 
probe placed over your heart.  Following this, a small ultrasound wand will 
be placed over your heart and in the notch above your breast bone to 
measure the amount of blood pumped from your heart. 
 
Next, while seated, a cuff will be placed on your non-dominant forearm. A 
technique called flow-mediated dilation will be used on your upper non-
dominant arm to measure the size of your artery and the speed of blood 
flowing through it. To do this a probe with ultrasound gel will be placed on 
your upper arm. The cuff on your forearm will be inflated to ~200mmHg for 
5 minutes and then released.  
 
After 30 minutes of rest, blood vessel function will be measured using a 
technique called venous strain-gauge plethysmography. In this procedure, 
your dominant arm will be elevated above heart level and a rubber strain 
gauge (similar to an elastic band) will be placed around the largest part of 
your forearm. A cuff will be placed on your wrist and will be inflated to a 
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pressure above systolic BP (generally close to 200mmHg). The cuff on your 
upper arm will be inflated to ~40 – 60 mmHg for 10 seconds and then 
released for 5 seconds, and this will continue for 1 minute. Next, the upper 
arm cuff will be inflated to 200mmHg for 5 minutes and then released. 
Forearm blood flow will be measured every 10 seconds for 1 minute after 
the cuff is released.  
 
You will then perform a bout of isometric handgrip exercise. You will 
squeeze the handgrip 4 times, holding it at 30% of your maximum squeeze 
for 2 minutes, and switching back and forth between hands (e.g., right hand 
squeeze for 2 minutes, left hand squeeze for 2 minutes, then another right 
hand squeeze and another left hand squeeze). You will have a minute to rest  
between each squeeze. Your blood pressure and heart rate will be measured 
throughout.  We will also measure blood flow in your upper non-dominant 
arm using the ultrasound as we did  
before, and blood flow from your heart by holding a small ultrasound wand 
in the notch above your breast bone. 
 
You will be asked to rate how hard you feel you are working on a scale of 1 
to 10 repeatedly throughout the exercise.  Following the exercise, the flow-
mediated dilation and venous strain-gauge plethysmography procedures will 
be repeated. 
 
Visit 5 (approximately 30 minutes) - OPTIONAL: 
 
Twelve hours after your last meal, and after lying down for 30 minutes, your 
blood will be taken. Five mL of blood will be collected from a vein in your 
arm by a registered practicing nurse. We will use this blood sample to 
measure blood values of nervous system activity (“fight or flight” system), 
and oxidative stress (chemical reaction which can have a negative effect on 
many cells of the body including the heart and blood vessels). 
 
Training Days (approximately 30 minutes) 
 
You will visit the laboratory 3 times per week, for a total of 10 weeks. The 
handgrip exercise will be identical to the one you performed on Visit 4 (4, 2 
minute squeezes, switching hands with each squeeze, with a minute of rest 
between). Again, squeezes will be performed at 30% of your hardest 
squeeze. All of your sessions will be monitored by an exercise trainer, and 
your blood pressure and heart rate will be measured before each session, the 
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same way as described above. We will monitor any changes in diet, exercise 
or medication at each visit. 
 
POTENTIAL RISKS AND DISCOMFORTS 
 
You may experience tendonitis in the tendons of the exercising arms with 
handgrip exercise however this risk is low if the exercise is properly 
performed. You may experience numbness and/or tingling in your arm or 
hand while the cuff(s) are inflated during our measurements. The gel used to 
image your blood vessels and/or the sticker-electrodes used to measure your 
heart rate may cause a rash, but this does not happen often. The cold water 
task may result in numbness and/or tingling, as well as a really cold 
sensation in your hand while it is in the cold water. To minimize this risk, 
we will place towels around your hand and the task will only last 2-minutes 
(which is well at the bottom of the 2-10 minute range typically used). If you 
choose to participate in the blood sampling portion of the study, the blood 
draws will be taken by a registered nurse under completely sterile 
conditions. You may experience some local discomfort when the needle is 
inserted, and there is a small risk of infection. However, once the needle is 
removed, pressure will be placed on the site in order to have as little bruising 
as possible. 
 
Please contact one of the study investigators if you feel any adverse effects 
from completing any portion of the study, and/or if you have any questions 
or concerns. Study investigators will reinforce proper exercise technique 
throughout the study. If you experience any adverse effects during any 
testing procedure, emergency responses will be provided. 
 
POTENTIAL BENEFITS TO PARTICIPANTS AND/OR TO SOCIETY 
 
You may or may NOT experience a lower blood pressure at rest or during 
your activities of daily life after each part of the study. In addition, you may 
or may not have improvements in other parts of your cardiovascular system 
(e.g., reduced tension in certain blood vessels of your body).  
 
If we prove our theories, isometric handgrip training may be a possible 
exercise option to lower blood pressure. 
 
COMPENSATION FOR PARTICIPATION 
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You will receive a Human Kinetics T-shirt for your participation. 
 
CONFIDENTIALITY 
 
Any information that is obtained in connection with this study and that can 
be identified with you will remain confidential and will be disclosed only 
with your permission. 
 
To ensure your confidentiality, following your consent, you will be assigned 
an identification number. Your name will not be mentioned in any 
publication or presentation, and you will be identified with only your 
identification number on all collection tools (electronic or otherwise), with 
the exception of the medical and physical activity readiness questionnaires. 
All paper data will be stored in the locked laboratory (PACR Lab, Room 
#240, Human Kinetics Building, University of Windsor) of the study 
investigators. Information stored on computer will be password-accessible 
only. With respect to final disposal, all paper records (including medical and 
physical activity readiness questionnaires) will be shredded after 5 years. 
           
PARTICIPATION AND WITHDRAWAL 
 
You can choose whether to be in this study or not, and your participation or 
lack of it will not influence your participation in another study. If you 
volunteer to be in this study, you may withdraw at any time without 
consequences of any kind. You may also refuse to answer any questions you 
do not wish to answer and still remain in the study. The investigator may 
withdraw you from this research if circumstances arise which warrant doing 
so (e.g., medication, nutrition and/or physical activity change). 
 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE 
PARTICIPANTS 
 
Results will also be posted on the University of Windsor’s Research Ethics 
Board (REB) website  
(http://www.uwindsor.ca/reb) at the completion of the study. 
SUBSEQUENT USE OF DATA 
 
These data may be used in subsequent studies, in publications and in 
presentations however your privacy will be upheld with the use of your 
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unique subject identification number under all circumstances. 
RIGHTS OF RESEARCH PARTICIPANTS 
 
You may withdraw your consent at any time and discontinue participation 
without penalty. If you have questions regarding your rights as a research 
subject, contact: Research Ethics Coordinator, University of Windsor, 
Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext. 3948; e-mail: 
ethics@uwindsor.ca 
 
SIGNATURE OF RESEARCH PARTICIPANT/LEGAL REPRESENTATIVE 
 
I understand the information provided for the study “Isometric exercise 
training and blood pressure regulation: exploring sex- and age-related 
differences” as described herein. My questions have been answered to my 
satisfaction, and I agree to participate in this study. I have been given a copy 
of this form. 
 
______________________________________ 
Name of Participant 
 
______________________________________  
 _______________
____ 
Signature of Participant           
Date 
 
SIGNATURE OF INVESTIGATOR 
 
These are the terms under which I will conduct research. 
 
_____________________________________  
 _______________
_____ 
Signature of Investigator           
Date 
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Appendix E: Letter of Information for Consent to Participate in Research Form 
 
 
 
Title of Study: Isometric Exercise Training and Blood Pressure 
Regulation: Exploring Sex- and Age-Related Differences 
 
You are asked to participate in a 10-week isometric exercise training 
research study conducted jointly between the University of Windsor and The 
University of Northampton (Northampton, England). Your total time 
commitment for the entire study is ~ 22 hours: a) determining if you qualify 
to participate in the study (~I hour), b) testing days (~6 hours total), and c) 
exercise training (~30 minutes, 3X per week; ~15 hours total). 
 
If you have any questions or concerns about the research at the University of 
Windsor site, please feel to contact Cheri McGowan, PhD (519-253-3000 
ext. 2451; mcgowanc@uwindsor.ca), or Kevin Milne, PhD (519-253-3000 
ext. 2452; kjmilne@windsor.ca). For questions or concerns during non-
working hours, please contact Cheri McGowan, PhD via cell phone at 734-
904- 8488. 
 
PURPOSE OF THE STUDY 
 
Our research groups in Canada and England have shown that isometric 
(constant squeeze) exercise training using a handgrip (isometric handgrip 
(IHG) training) and leg machine (isometric leg training) lowers resting blood 
pressure inyounger and older people who have high blood pressure, and 
even in those with normal blood pressure. However, we do not know why it 
works. Not all people have a drop in their blood pressure after training, so 
identifying those people it will help is also important.  
 
The part of the study at the University of Windsor site,willsee if certain tasks 
(e.g., a handgrip squeeze or a simple math test) that raise your heart rate and 
blood pressure can predict who will have a drop in their resting blood 
pressure after 10 weeks handgrip training, 3 times a week. In addition, we 
will test the function of some of your blood vessels, as well as the  
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activity of your nervous system. Our study will also see whether men and 
women respond differently, and if younger and older people respond 
differently.  
In order to participate in this study you must have a normal blood pressure 
(<140/90 mmHg). You must be 18-40 years or 60-80 years of age to 
participate in this study. If you have a disorder or any known ailments or are 
taking any medications that influence your cardiovascular system you may 
be ineligible to participate. If you have a physical limitation impairing your 
ability to exercise you may also be ineligible to participate.  
 
PROCEDURES 
 
If you volunteer to participate in this study, you will be asked to attend the 
following: 
 
Visit 1 (approximately 30 minutes): 
 
You will meet with the study investigators at the Physical Activity and 
Cardiovascular Research (PACR) Laboratory (Room #240, Human Kinetics 
Building, University of Windsor, Windsor, Ontario, Canada) where you will 
receive a consent form and information sheet about the study. At this time, 
one of the study investigators will explain all parts of the study. If you are 
still interested in participating in the study, you will be asked to sign the 
consent form and fill out a brief medical questionnaire.You will then have 
your blood pressure measured in your upper arm, similar to how it is taken at 
a doctor’s officeIn brief, your resting blood pressure will be measured in 
your upper dominant arm after 10 minutes of seated rest. Your blood 
pressure will be measured 4 times, with 2-minutes of rest between measures. 
 
 
Visit 2 (approximately 30 minutes): 
 
If you are still interested in participating in the study, and you are initially 
eligible after Visit 1, you will visit the lab again.  First, you will have your 
resting blood pressure measured again, in the same manner as the first visit. 
If your blood pressure is still <140/90 mmHg, you will then practice all parts 
of the study including the math task and the handgrip exercise. After you 
practice all parts of the study, you will be asked to complete a physical 
activity readiness questionnaire called a PAR-Q, and if needed, a more 
detailed form called the PAR-MedX. You will also receive two letters to be 
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taken to your health care provider. One will notify your health care provider 
of your involvement in the study and the second is to be signed by your 
health care provider and returned to us. Upon receiving this document you 
will then choose the dates to complete the 3 days of testing. All testing days 
will be separated by at least 24 hours. 
 
Testing Days (Visits 3-4): 
 
You will be asked not to exercise vigorously (e.g., exercise that causes you 
to breath really hard and sweat heavily) or drink alcohol for 24 hours before 
each testing day, and to avoid caffeine for at least 12 hours before. All 
testing will take place at the same time of day, in a quiet, temperature-
controlled room, following a light meal for visit 3 and 4 hours after eating 
for visit 4. On testing days, you will be asked to go to the washroom before 
testing, as a full bladder can increase your blood pressure. 
 
All 3 testing days will happen again after 10 weeks of handgrip training 
(Week 11). You will train 3 times per week, for a total of 10 weeks. You 
will perform 4, 2-minute squeezes at 30% of your maximum squeeze, using 
both hands (each separated by 1 minute of rest) on a computerized handgrip. 
All training sessions will be supervised by an exercise trainer, where your 
resting blood pressure and heart rate will be measured before each session. 
Training sessions should not last longer than 30 minutes. Your exercise, 
nutritional, and medication habits (where necessary) will be monitored in 
exercise log books throughout the study to make sure they do not change. 
 
 
Visit 3 (approximately 3 hours): 
 
Upon entering the lab, your resting blood pressure and heart rate will be 
measured in the same way that it was measured in the previous visits. After 
that, your blood pressure and heart rate will be measured continuously for 10 
minutes. Continuous blood pressure will be measured by a small cuff placed 
around your middle finger on your dominant hand, and continuous heart rate 
will be measured by using 3 sticker electrodes that will be placed on your 
chest. 
 
After that, we will remove the finger blood pressure cuff, but the cuff on 
your upper arm and the sticker electrodes on your chest will stay in place. 
You will then perform 3 tasks in random order (i.e., chosen by chance). 
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These include: 1) a short handgrip exercise, 2) a task where you place your 
hand in cold water, and 3) a math task.  
 
The short handgrip task will involve you performing a single 2-minute 
squeeze at 30% of your maximum squeeze on a computerized handgrip 
using your non-dominant hand. The math task will involve looking at a 
computer and subtracting a 2-digit number from a 4-digit number displayed 
and responding with your answer aloud. You will be shown 25 numbers in 
total and will have 5 seconds answer each one.  Finally, the cold water task 
will involve you placing your             
right hand in cold water (~4°C) for 2-minutes.Heart rate and blood pressure 
(every minute) will be measured during and after each task, and once both 
heart rate and blood pressure have stabilized, you will begin the next task. 
 
At the end of the testing session, we will send you home with a machine that 
will record your blood pressure for the next 24-hours. The morning 
following, you will return this device to us. 
 
Visit 4 (approximately 3 hours): 
 
First, your resting blood pressure and heart rate will be measured in the same 
way as it was on your other visits.  
 
Next, we will take a picture of an artery in your heart using an ultrasound 
probe placed over your heart.  Following this, a small ultrasound wand will 
be placed over your heart and in the notch above your breast bone to 
measure the amount of blood pumped from your heart. 
 
Next, while seated, a cuff will be placed on your non-dominant forearm. A 
technique called flow-mediated dilation will be used on your upper non-
dominant arm to measure the size of your artery and the speed of blood 
flowing through it. To do this a probe with ultrasound gel will be placed on 
your upper arm. The cuff on your forearm will be inflated to ~200mmHg for 
5 minutes and then released.  
 
After 30 minutes of rest, blood vessel function will be measured using a 
technique called venous strain-gauge plethysmography. In this procedure, 
your dominant arm will be elevated above heart level and a rubber strain 
gauge (similar to an elastic band) will be placed around the largest part of 
your forearm. A cuff will be placed on your wrist and will be inflated to a 
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pressure above systolic BP (generally close to 200mmHg). The cuff on your 
upper arm will be inflated to ~40 – 60 mmHg for 10 seconds and then 
released for 5 seconds, and this will continue for 1 minute. Next, the upper 
arm cuff will be inflated to 200mmHg for 5 minutes and then released. 
Forearm blood flow will be measured every 10 seconds for 1 minute after 
the cuff is released.  
 
You will then perform a bout of isometric handgrip exercise. You will 
squeeze the handgrip 4 times, holding it at 30% of your maximum squeeze 
for 2 minutes, and switching back and forth between hands (e.g., right hand 
squeeze for 2 minutes, left hand squeeze for 2 minutes, then another right 
hand squeeze and another left hand squeeze). You will have a minute to rest 
between each squeeze. Your blood pressure and heart rate will be measured 
throughout.  We will also measure blood flow in your upper non-dominant 
arm using the ultrasound as we did before, and blood flow from your heart 
by holding a small ultrasound wand in the notch above your breast bone. 
 
You will be asked to rate how hard you feel you are working on a scale of 1 
to 10 repeatedly throughout the exercise.  Following the exercise, the flow-
mediated dilation and venous strain-gauge plethysmography procedures will 
be repeated. 
 
Visit 5 (approximately 30 minutes) - OPTIONAL: 
 
Twelve hours after your last meal, and after lying down for 30 minutes, your 
blood will be taken. Five mL of blood will be collected from a vein in your 
arm by a registered practicing nurse. We will use this blood sample to 
measure blood values of nervous system activity (“fight or flight” system), 
and oxidative stress (chemical reaction which can have a negative effect on 
many cells of the body including the heart and blood vessels). 
 
Training Days (approximately 30 minutes) 
 
You will visit the laboratory 3 times per week, for a total of 10 weeks. The 
handgrip exercise will be identical to the one you performed on Visit 4 (4, 2 
minute squeezes, switching hands with each squeeze, with a minute of rest 
between). Again, squeezes will be performed at 30% of your hardest 
squeeze. All of your sessions will be monitored by an exercise trainer, and 
your blood pressure and heart rate will be measured before each session, the 
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same way as described above. We will monitor any changes in diet, exercise 
or medication at each visit. 
 
POTENTIAL RISKS AND DISCOMFORTS 
 
You may experience tendonitis in the tendons of the exercising arms with 
handgrip exercise however this risk is low if the exercise is properly 
performed. You may experience numbness and/or tingling in your arm or 
hand while the cuff(s) are inflated during our measurements. The gel used to 
image your blood vessels and/or the sticker-electrodes used to measure your 
heart rate may cause a rash, but this does not happen often. The cold water 
task may result in numbness and/or tingling, as well as a really cold 
sensation in your hand while it is in the cold water. To minimize this risk, 
we will place towels around your hand and the task will only last 2-minutes 
(which is well at the bottom of the 2-10 minute range typically used). If you 
choose to participate in the blood sampling portion of the study, the blood 
draws will be taken by a registered nurse under completely sterile 
conditions. You may experience some local discomfort when the needle is 
inserted, and there is a small risk of infection. However, once the needle is 
removed, pressure will be placed on the site in order to have as little bruising 
as possible. 
 
Please contact one of the study investigators if you feel any adverse effects 
from completing any portion of the study, and/or if you have any questions 
or concerns. Study investigators will reinforce proper exercise technique 
throughout the study. If you experience any adverse effects during any 
testing procedure, emergency responses will be provided. 
 
POTENTIAL BENEFITS TO PARTICIPANTS AND/OR TO SOCIETY 
 
You may or may NOT experience a lower blood pressure at rest or during 
your activities of daily life after each part of the study. In addition, you may 
or may not have improvements in other parts of your cardiovascular system 
(e.g., reduced tension in certain blood vessels of your body). 
 
If we prove our theories, isometric handgrip training may be a possible 
exercise option to lower blood pressure. 
 
COMPENSATION FOR PARTICIPATION 
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You will receive a Human Kinetics T-shirt for your participation. 
 
CONFIDENTIALITY 
 
Any information that is obtained in connection with this study and that can 
be identified with you will remain confidential and will be disclosed only 
with your permission. 
 
To ensure your confidentiality, following your consent, you will be assigned 
an identification number. Your name will not be mentioned in any 
publication or presentation, and you will be identified with only your 
identification number on all collection tools (electronic or otherwise), with 
the exception of the medical and physical activity readiness questionnaires. 
All paper data will be stored in the locked laboratory (PACR Lab, Room 
#240, Human Kinetics Building, University of Windsor) of the study 
investigators. Information stored on computer will be password-accessible 
only. With respect to final disposal, all paper records (including medical and 
physical activity readiness questionnaires) will be shredded after 5 years. 
           
PARTICIPATION AND WITHDRAWAL 
 
You can choose whether to be in this study or not, and your participation or 
lack of it will not influence your participation in another study. If you 
volunteer to be in this study, you may withdraw at any time without 
consequences of any kind. You may also refuse to answer any questions you 
do not wish to answer and still remain in the study. The investigator may 
withdraw you from this research if circumstances arise which warrant doing 
so (e.g., medication, nutrition and/or physical activity change). 
 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE 
PARTICIPANTS 
 
Results will also be posted on the University of Windsor’s Research Ethics 
Board (REB) website (http://www.uwindsor.ca/reb) at the completion of the 
study. 
SUBSEQUENT USE OF DATA 
 
These data may be used in subsequent studies, in publications and in 
presentations however your privacy will be upheld with the use of your 
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unique subject identification number under all circumstances. 
RIGHTS OF RESEARCH PARTICIPANTS 
 
You may withdraw your consent at any time and discontinue participation 
without penalty. If you have questions regarding your rights as a research 
subject, contact: Research Ethics Coordinator, University of Windsor, 
Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext. 3948; e-mail: 
ethics@uwindsor.ca 
 
SIGNATURE OF INVESTIGATOR 
 
These are the terms under which I will conduct research. 
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Appendix F: Medical Questionnaire 
 
Last Name _______________________________________________   First Name _______________________________________  
Height:_______________________ Weight: _______________________ Date of Birth (Month/Yr) _______ 
Phone   (   ) ____________________________________________  Postal Code _____________________ 
 
FOR EMERGENCY NOTIFY:  Name ___________________   Relationship _______________________________________  
Address _________________________________________________________   Phone ____________________________________  
Family Doctor's Name _______________________________________   Date of Last Physical _______________________________  
 
Please Check Yes or No: Yes  No 
1. Have you ever been hospitalized? ............................................................................................................................ oo  
        If yes, please specify?
 
_______________________________________________________________________________________
 
 Have you ever had surgery? ..................................................................................................................................... oo 
         If yes, please specify?
 
_______________________________________________________________________________________
 
2. Are you presently taking any medications or pills (including aspirin and other over-the-counter 
medication)? oo 
 If yes, please specify?
 
_______________________________________________________________________________________
 
 Are you presently taking any vitamins, supplements, and/or herbal supplements? .................................................. oo 
3. Do you have any allergies (medicine, food, bees or other stinging insects)? ........................................................... oo 
 If yes, please specify?
 
_______________________________________________________________________________________
 
4. Have you ever passed out during or after exercise?................................................................................................. oo 
 Have you ever been dizzy during or after exercise? ................................................................................................. oo 
 Have you ever had chest pain during or after exercise? ........................................................................................... oo 
 Do you have high blood pressure (hypertension) or low blood pressure (hypotension)? .......................................... oo 
       Have you ever been told that you have a kidney problem?  ..................................................................................... oo 
 Have you ever been told that you have joint instability?  .......................................................................................... oo 
       Have you ever been told that you have a stomach problem?  .................................................................................. oo 
       Have you ever been told that you have a heart problem?  ........................................................................................ oo 
       Have you ever been told that you have a heart murmur? ......................................................................................... oo 
 Do you have a machine that regulated your heart beat?  ......................................................................................... oo 
       Have you ever had racing of your heart or skipped heartbeats? ............................................................................... oo 
 Has anyone in your family died of heart problems or a sudden death before age 50? ............................................. oo 
5. Do you have any skin problems (itching, rashes, acne)? .......................................................................................... oo 
       If you get a cut, does it take you a long time to stop bleeding? ................................................................................. oo 
 If you experience a blow to a muscle, do you bruise easily?  ................................................................................... oo 
6. Do you have Diabetes?     ........................................................................................................................................ oo 
7. Do you have Asthma or any other breathing problems?       ..................................................................................... oo 
         If yes, please specify?
 
_______________________________________________________________________________________
 
8. Do you have any type of cardiovascular disease? .................................................................................................... oo 
If yes, please specify?
_______________________________________________________________________________________
 
9. Have you had any other medical problems (infectious mononucleosis, etc.)? .......................................................... oo 
10. Have you had any medical problems since your last physical? ................................................................................ oo 
11. Do you smoke?                  ........................................................................................................................................ oo 
12.  Do you aerobically exercise (e.g., walking) for > 30 minutes, > 2 times per week?  ................................................. oo 
Please explain any physical limitations that may prevent you from completing this study: 
 __________________________________________________________________________________________________  
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Appendix G: Resting BP Device 
 
 
DinamapCarescape v100, Critikon, Tampa, Florida, USA 
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Appendix H: Physical Activity Readiness Questionnaire (PAR-Q) 
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Appendix I: Health Care Provider Documents 
 
 
 
HEALTH CARE PROVIDER DOCUMENT 
 
 
Date:  __________________. 
 
 
 
Dear __________________, 
 
 
Your patient, ___________________________________, has expressed interest in participating 
in our research study in the Department of Kinesiology at the University of Windsor 
entitled:  Isometric Exercise Training and Blood Pressure Regulation: Exploring Sex- 
and Age-Related Differences (see attached Letter of Information for Consent for 
details). We ask that you sign the attached form and return it to us, along with the 
PARmed-X (where applicable). 
 
Thank-you for your help, and we appreciate your support. Please do not hesitate to 
contact us if you have any questions or concerns. 
 
 
 
Sincerely, 
Dr. Cheri McGowan, PhD 
Dr. Kevin Milne, PhD 
Assistant Professors 
Department of Kinesiology 
Faculty of Human Kinetics 
University of Windsor 
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Date:  __________________. 
 
 
Dear Drs. McGowan and Milne, 
 
 
 
I, ___________________________________, acknowledge that my patient ____________________has 
expressed interest in participating in our research study in the Department of 
Kinesiology at the University of Windsor entitled:  Isometric Exercise Training and 
Blood Pressure Regulation: Exploring Sex- and Age-Related Differences. I have 
approved my patient’s participation in your study. 
 
 
 
 
___________________________________________________________________ 
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Appendix J: ECG Leads and Electrodes 
 
 
 
 
 
 
 
AD Instruments, Colorado Springs, Colorado, USA 
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Appendix K: Data Acquisition System 
 
 
 
Powerlab ML 870/P, AD Instruments, Colorado Springs, Colorado, USA 
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Appendix L: Isometric Handgrip (IHG) 
 
 
 
ZonaPLUS, Zona HEALTH, Boise, Idaho, USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
140 
 
Appendix M: 24-Hour Ambulatory BP Device 
 
 
 
SpaceLabs Inc., Redmond, Washington, USA 
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Appendix N:  Exercise Journal 
Name:__________________________________________________________________ 
Date What was your 
maximum 
contraction 
value? 
RightmaxLeftmax 
Did you complete 
two sets with each 
hand? 
(% at end of session) 
Have you had any 
new medications 
prescribed to you 
and/or have you 
started to take any 
new over the 
counter products?  
Have you 
had any 
dietary 
changes? If 
yes, please 
describe. 
Have you had any 
physical activity 
changes? If yes, 
please describe. 
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